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Since the introduction of antiretroviral therapy, the survival rate of infected HIV patients 
has been on the rise with a predicted increase by 2030. The longer a person lives with the 
virus, the more prone to HIV-associated chronic diseases he or she becomes, but it is not 
clear whether these diseases are solely from aging with the virus or from long-term use of 
antiretroviral therapy. Scientists demonstrated that the introduction of antiretroviral 
therapy led to an increased life expectancy yet early onset of comorbidities; however, 
they failed to address the challenges that people 50 years old or older face, as well as 
other factors affecting their quality of life. The purpose of this study, driven by both 
social constructivism as well as the advocacy worldview, was to explore the lived 
experiences of participants older than 50 living with HIV to gain an understanding of 
how long-term use of antiretroviral therapy relates to the onset of comorbidities, which 
would lead to a new understanding of the challenges they face. These findings could give 
healthcare providers insights on the population in question, their challenges, and how to 
better address their concerns. The methodology of the study was a phenomenological 
approach; data were collected through responses from 10 participants during recorded 
telephone interviews. The recorded data were transcribed before being analyzed using 
Nvivo software. The results indicated that these participants live in daily survivorship 
filled with constant struggle between a series of comorbidities that develop overtime. 
Additionally, their journey is not only coupled with unmet needs of today but also with 
uncertainties of tomorrow. The findings can improve the current social conditions of 
those who are older and suffering from HIV by providing information to healthcare 
professionals who can improve or maintain the health of this population.  
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Chapter 1: Introduction to the Study 
In this study, I looked at challenges of aging with the HIV virus and comorbidities 
that arise. I explored the lived experiences of people over 50 years old as they age with 
HIV infection as well as challenges that they encounter from being on antiretroviral 
therapy (ART) for a long time. Since the introduction of ART as a treatment for HIV, life 
expectancy has been prolonged, reducing the mortality of the affected from 2.2 to 1.8 
million (Negin, Mills, & Barnighausen, 2012). As of 2015, 50% of HIV individuals in the 
United States are 50 years old or older (Adekeye, Heiman, Onyeabor, & Hyacinth, 2012). 
However, prolonged life expectancy comes with challenges like comorbidities (Cahil & 
Valadez, 2013). The current literature does not address the challenges of HIV patients 
older than 50 living with diagnosed comorbidities (Cahill & Valadez, 2013). For this 
study, I interviewed HIV patients older than 50 with at least one comorbidity, who had 
been living with HIV for at least 20 years, and had been taking antiretroviral therapy 
which enabled me to seek understanding of their experiences. This information will 
improve their current social condition by improving the knowledge of healthcare 
professionals, thus promoting their overall health and quality of life.  
In the following chapter, I will briefly outline information on the background of 
the study, the problem statement, the purpose, the research questions, and the theoretical 
framework. Additionally, I will address the nature of the study, the key definitions used, 
the assumptions, the scope and delimitations, the limitations, and the significance of the 






Advances in research have led to an increased life expectancy among people 50+ 
living with HIV. Because life expectancy for this population is expected to increase 
further, researchers should examine challenges such as new onset of chronic diseases 
surrounding normal aging and aging with both the virus and usage of ART (Deeks, 
Lewin, & Havlir, 2013; Samji et al., 2013). Rueda, Law, and Bourke (2014) and Negin, 
Mills et al. (2012) noted that prolonged use of ART has made this population group prone 
to chronic diseases, with 65% of them reporting an onset of up to two chronic diseases 
since testing positive. The literature does not currently address the impact of such 
comorbidities on the life of HIV patients older than 50.  
The aging population has a higher incidence of complications from comorbidities 
that arise from living with HIV virus (National Institutes of Health [NIH], 2016). As 
such, adequate treatment as well as proper monitoring is crucial for this growing group 
(NIH, 2016). Guaraldi et al. (2011) and Deeks et al. (2013) have shown evidence that 
there is limited access to health services as well as weak retention in care for HIV 
individuals over 50 years old. Additionally, Cahil and Valadez (2013) reported a lack of a 
proper system that would serve this group facing multimorbidity issues. Research has not 
addressed the rationale behind this weak retention and whether HIV individuals older 
than 50 are aware of the negative impact of being on ART, aging with the virus, and 





Brennen, Emlet, and Eady (2011) reported that this population is affected by 
social issues such as depression, stigma, and neglect, suggesting a lack of support from 
their respective communities; however, the literature does not provide an understanding 
of the experiences of those living and aging with HIV. Brennen et al. also outlined the 
lack of adequate policies to address issues of this aging group mainly due to the lack of 
basic knowledge and understanding of their needs and the challenges they face. Rueda et 
al. (2014) recommended that studies should be conducted that focus on exploring 
challenges of the aging population living with HIV and comorbidities. Through this 
study, I focused on gaining a better understanding of the lived experiences of people 50+ 
living and aging with HIV and comorbidities and the challenges that influence their lives 
as HIV-positive individuals.  
Problem Statement 
HIV was once a death sentence but infected individuals’ life expectancies have 
been increasing since the introduction of ART (Negin, Mills et al., 2012). However, this 
victory has been coupled with the onset of chronic diseases either from old age, aging 
with ART, or a combination of both (Rueda et al., 2014). Although the literature has 
failed to address the challenges that this population group faces as well as other factors 
affecting their quality of life, it has shown evidence of HIV being linked to early onset of 
chronic comorbidities (Cahil & Valadez, 2013). Because the percentage of people 50+ 
living and aging with HIV and the success of ART are expected to increase further by 





Purpose of the Study 
The purpose of this qualitative phenomenological study was to explore the lived 
experiences of participants 50 years old or older living with HIV. This enabled me to gain 
an understanding of the challenges they face as they age with the virus and comorbidities. 
The findings will provide information that can improve the quality of life for this 
population. 
Research Questions 
The study addresses the following research questions (RQs): 
RQ1: What are the experiences of people 50+ living with HIV? 
RQ2: How do people 50+ describe their experiences with HIV? 
RQ3: How do HIV-positive patients older than 50 describe the challenge of living 
with HIV and diagnosed comorbidities?  
These were questions and prompts that I presented to the participants of the study 
to answer my RQs: 
1. Tell me about your experiences living with HIV.  
2. Tell me about the effects HIV has had on your daily life and your 
relationships with family, friends, and coworkers.  
3. Describe your awareness of sexual risks associated with HIV infection.  
4. Tell me about your health care experiences since testing positive for HIV.  






6. What is your experience with those HIV services?  
7. Describe your experience with support from your family or lack of support. 
8. Describe any experiences you might have had where friends, family, 
coworkers, or anyone else avoided you because of being HIV positive.  
9. Describe your experience with your local HIV clinic.  
10. Describe your relationship with HIV medical specialists? 
11. Describe your knowledge on follow up care with HIV specialists when living 
with HIV.  
12. Describe your experience of living with HIV and being on ART. 
13. Describe your awareness of the impact of long-term use of ART.  
14. What is your experience of living with HIV and being on multiple 
medications? 
15. What is your experience of coping with side effects of multiple medications?  
16. Describe whether you believe people in general have a decline in their health 
as they age.  
17. Describe your knowledge of aging with the HIV virus.  
18. Describe your knowledge of health complications that arise from getting older 
with HIV.  






20. Describe your knowledge of side effects of multiple medications used to treat 
complications of old age. 
21. What is your experience of coping with the combination of new comorbidities 
and HIV since diagnosis?  
22. Describe your current quality of life.  
23. Outline factors that could improve your current quality of life. 
Conceptual Framework  
I used two frameworks for this study: social constructivism and advocacy 
worldview. Berger and Luekmann introduced the social constructivism in 1966. They 
outlined three main propositions in their framework: the foundation of knowledge in 
everyday life, society as an objective reality, and society as a subjective reality (Berger & 
Luckmann, 1966). I also used the advocacy worldview framework, which was introduced 
in 1997 by Heron and Reason. Heron and Reason (1997) outlined three propositions to 
their framework: the ontology subjective-objective, the extended epistemology, and 
axiology. I will provide more detail on these in the literature review.  
The constructivist framework was appropriate because I focused on exploring the 
lived experiences of people 50+ living with HIV and their comorbidities. To recommend 
appropriate actions, a researcher needs an understanding of the phenomenon (Berger & 
Luckmann, 1966), which is best described by those experiencing the phenomenon for 
themselves. The advocacy worldview is also appropriate for the purpose of understanding 





information to improve their social living conditions. The advocacy worldview allows a 
researcher to use knowledge gathered from experience to improve the quality of life of 
those involved in the phenomenon in question (Herron & Reason, 1997).  
The phenomenology of the study was to assess the lived experiences of people 
50+ living with HIV. I attempted to identify their experiences, understand them from 
their perspectives, and understand how these experiences affected them. People typically 
understand others’ perceptions of things based upon their experiences (Berger & 
Luckmann, 1966), which is another reason why social constructivism was the approach I 
used. 
Using a qualitative approach via open-ended interviews enabled me to understand 
lived experiences by providing detailed information on their experiences. Qualitative 
interviews are essential when seeking better understanding of participants’ experiences, 
as they help participants in elaborating into as much depth as possible on their opinions 
and experiences of the topic at hand (Milena, Dainora, & Alin, 2008).  
Nature of the Study 
Scientists choose a phenomenological approach when they seek to identify human 
experiences pertaining to a specific phenomenon described by the participants (Creswell, 
2009), which made it the appropriate choice for this qualitative study. I obtained primary 
data via recorded telephone interviews. The included participants, recruited from an 
AIDS agency and the online HIV community, were 50 years old or older, were living 





testing positive for HIV. Only those that have a connection to the phenomenon in 
question were included in the study. I used Nvivo software to analyze the data because it 
is adequate to analyze large qualitative texts (Zamawe, 2015).  
Definitions 
Comorbidity: A specific entity that develops during the clinical course of a patient 
with a specific disease being studied (Valderas, Starfield, Sibbald, Salisbury, & Roland, 
2009).  
Multimorbidity: Co-occurrence of multiple chronic diseases seen in a patient 
(Valderas et al., 2009).  
Assumptions 
I assumed that participants would have appropriate knowledge of the topic based 
on their experiences. I also assumed that through these experiences I would gain a better 
understanding of participants’ daily life and challenges. Another assumption was that 
there would be institutions that would allow others in similar situations to interact, which 
is why I included interview questions to determine whether my participants were enrolled 
at an HIV community center, interacting and sharing their challenges with others.  
Based on the advocacy worldview framework, I assumed the information 
gathered through the interviews could enable me to outline the need of the population 
sample to improve their conditions. Another assumption from this framework is that 
community-based research is critical, as it shows the relationship between the person 





1997). Although this assumption would be important for certain qualitative studies, I used 
an interview-based approach, assuming that the results from the interviews would enable 
me to understand participants’ experiences and improve the social conditions in which 
they live.  
I also assumed that the participants have lived with HIV for at least 20 years and 
would share their experiences and challenges. Another assumption was that using a 
recorded semistructured telephone interview would make the participants comfortable in 
sharing their lived experiences. Semistructured interviews are assumed adequate to obtain 
sufficient insight on the experiences and challenges of the population in question.  
Scope and Delimitations 
I studied the experiences with HIV among individuals older than 50 because the 
current literature lacks publications on the challenges this population endures. In the 
study, I outlined the challenges they face, providing an understanding of their 
perspectives that could be used to improve the quality of life for HIV-positive 
individuals. 
The inclusion criteria were participants 50 years old or older, living with HIV for 
at least 20 years, on ART and with at least one comorbidity, while the exclusion criteria 
excluded newly diagnosed HIV patients and those not fluent in English. 
I used constructivism and advocacy/participatory frameworks in my study. The 
constructivism framework allows a researcher to gain an understanding of the 





studied (Creswell, 2009). The advocacy framework outlines that information gathered 
from the participants will be used to improve specific social issues as well as their quality 
of life (Creswell, 2009). Using these frameworks was essential in seeking to understand 
the challenges HIV patients 50+ face when living with the virus.  
Researchers use the post-positivism framework to identify and/or assess causes 
that influence a particular outcome (Creswell, 2009). Because this involves measurement 
and experiments, it is better suited for quantitative research, meaning I did not use it for 
this study. Researchers use the pragmatism framework to answer to the “what” and 
“how” of research (Creswell, 2009). Because this framework includes both a quantitative 
and qualitative aspect, it is best suited for a mixed method study, so it was not used in my 
study.  
To ensure transferability, I provide step-by-step parameters of my methodology. 
Transferability, also known as external validity, is present when researchers present 
findings in enough detail that the study could be replicated (Shenton, 2004). A sufficient 
description of the phenomenon in question should be provided for the reader to grasp the 
context then adequately compare it to their own experience (Shenton, 2004). 
Limitations 
Limitations can arise in both quantitative and qualitative studies and are defined 
as influences occurring during a study and which the scientist cannot control (Baltimore 
County Public School, 2017). Because limitations can affect the overall result of the 





limitation was the difficulty in generalizing results to a population that does not share the 
phenomenon in question (Shenton, 2004). Because of the small number of participants 
included in the research, the overall study results might not be generalizable to a larger 
population (Anderson, 2010). The experiences and challenges gathered from the 
interviewees may also not reflect that of the entire population, even with similar 
background, as the study will only involve a smaller sample of participants. 
To avoid potential limitations regarding incentives for participants, I went through 
the process of pre-approval through the Institutional Review Board (IRB). An incentive 
should not be used for coercion but rather as a form of compensation for their agreed 
upon participation (Metropolitan State University, 2017). The incentive should be based 
on the subject time and expenses such as transportation (Metropolitan State University, 
2017). To assess the credibility of the results, a researcher must look at both the 
reliability and validity of the study (Anderson, 2010). I used respondent validation, 
allowing participants to view the collected data, to assure the accuracy of results.  
Significance 
The findings of this study could be useful in uncovering challenges HIV people 
50+ face and subsequently their experiences living with HIV and comorbidities. This 
insight could improve healthcare providers’ understanding of the needs of this group so 
they can address them appropriately. Gaining adequate understanding of this group’s 
experiences and needs could be key in not only promoting better care, such as screenings 





community programs as well as framing of proper policies tailored to improve their 
quality of life (Emlet, Frederiksen-Goldsen, & Kim, 2013). Sankar, Nevedal, Neufeld, 
Berry, and Luborsky (2011) have recommended that social issues and health limitations 
are present among HIV people 50+ and should be investigated further. These findings can 
be used to improve the current social conditions this group faces in hope of reducing their 
psychosocial burden and promoting and maintaining their health (Sankar et al., 2011).  
Summary 
HIV has become a chronic disease since the introduction of the use of ART. 
Because of the comorbidities that develop over time, it is crucial for healthcare providers 
treating older individuals with HIV to gain a full understanding of the issues these 
individuals face. While I briefly provided information on the steps used in conducting 
this phenomenological study in this chapter, in the following chapter I will elaborate in 






Chapter 2: Literature Review 
The purpose of this phenomenological study was to understand the lived 
experiences of people 50 years old or older living with HIV to address their challenges 
and improve their quality of life. In this chapter, I will report on the strategies used during 
the literature search, the social constructivism and participatory frameworks I used in the 
study was, and a literature review of key variables.  
Literature Search Strategy  
To adequately conduct this literature review, I searched for peer-reviewed full text 
articles in the Walden Library database using CINAHL and MEDLINE as well as Google 
Scholar and ProQuest Central. The articles were searched from the years 2010-2015 
using the following keywords: elderly, HIV, comorbidities, challenges, psychosocial 
issues, depression, multi- morbidity, health services, health policies, and antiretroviral 
therapy. After identifying five themes in my literature review—“increased life 
expectancy of people 50+ living with HIV,” “onset of comorbidities from aging with the 
HIV virus,” “limited access to tailored health services for people 50+ living with HIV,” 
“unaddressed psychosocial issues among 50+ HIV patients,” and “lack of policies and 
health care services for 50+ HIV patients”—I searched for articles that were relevant to 
each theme. For example, for “increased life expectancy of people 50+ living with HIV,” 
I used the Walden library database and Google Scholar search engines, using the key 





and 2015 to obtain more current literature. I only selected full peer-reviewed articles for 
each theme.  
Framework  
One of the frameworks I used was social constructivism, introduced in 1966 by 
Berger and Luekmann. Through this framework, the scientist seeks to understand a 
person’s reality and daily experience as well as how it affects their daily life (Berger & 
Luckmann, 1966). Berger and Luckmann (1966) stated that an individual’s reality is 
socially constructed, meaning what happens to us in our everyday lives reflects the reality 
as seen and interpreted by others. Additionally, others understand our perceptions of 
things based upon our experiences (Berger & Luckmann, 1966).  
Berger and Luckmann (1966) outlined three main propositions of their 
framework: the foundation of knowledge in everyday life, society as an objective reality, 
and society as a subjective reality. In the first proposition, knowledge is a reality acquired 
through everyday life from experience, familiarity, and interaction with others in society. 
In the second proposition, objective reality consists of the presence of institutions that 
provide a place where individuals can relate to each other when faced with specific 
situations. In the last proposition, they noted that humans, in participating in social 
institutions, participate in the objective reality created by the institutions included in the 
second proposition (Berger & Luckmann, 1966). 
Using social constructivism, Hjelm, Bard, Berntorp, and Apelqvist (2007) 





regarding their health 3 months postpartum. Their main goal was to assess the 
participants’ own perception of whether they perceived gestational diabetes (GDM) as a 
prediabetic condition (Hjelm et al., 2007), meaning a social constructivist framework was 
appropriate for their explorative study. Hjelm et al. found that overall, participants’ own 
beliefs about health and illness significantly affected their awareness of risk and self-care 
practice postpartum. While Swedish women showed a strong desire to acquire more 
information following their high-risk awareness, Middle Eastern women actively sought 
guidance from clinicians following their increased risk awareness (Hjelm et al., 2007). 
Hjelm et al. stressed that the exploration of the participants’ beliefs from their own 
respective lived experiences was a major strength in their study, which came from using 
the social constructivist framework.  
Because my study similarly explored participants’ perspectives, I chose a social 
constructivist approach. My intent was to understand the lived experiences of individuals 
50+ living with HIV. Nobody can grasp a better understanding of the challenges people 
50 years old or older face as they age with HIV than themselves. As Berger and 
Luckmann (1966) stated, such understanding would allow me to properly analyze the 
phenomenon in question. Understanding those experiences through their own reality 
could provide information specific enough to recommend appropriate actions that could 
better address their needs. 
The second framework I used was the advocacy worldview framework, 





constructivism framework lacked true knowledge from experience, so they introduced the 
participatory/advocacy worldview. Heron and Reason (1997) described this framework as 
one in which a person’s reality is seen as an interaction between the cosmos, the 
primordial reality, and the mind. In other words, his or her reality encompasses the 
interaction of several entities as a whole. Heron and Reason (1997) outlined three 
propositions to their framework: the ontology subjective-objective, the extended 
epistemology, and axiology. 
The first proposition describes the true nature of reality as a person interacts with 
the world in which he or she lives and what could be done to improve the environment in 
which he or she lives (Heron & Reason, 1997). This framework enables community-
based research to be conducted, as the research would assess people’s understanding of 
the environments in which they live in and what could be done to improve them. The 
second proposition notes that through community-based research, there is a primordial 
relationship between the person who holds the knowledge and the knowledge itself so 
that, the one who holds the knowledge shares that knowledge in four independent ways: 
experiential (participatory interaction with others and the world), presentational 
(representation of a person’s knowledge and experiences through stories), propositional 
(representation of an individual’s knowledge through facts and theories), and practical 
(representation of a person’s knowledge through action as seen in community-based 
research). The final proposition states what an individual considers as valuable being 





Hoelscher et al. (2012) conducted a community-based study using the advocacy 
worldview framework to assess the impact of two interventions on the prevalence of 
childhood obesity among minorities in central Texas. Throughout the 4-year program 
involving 97 schools, participants started reporting positive behaviors as well as 
improvements in their daily lives (Hoelscher et al., 2012). The authors noted that 
implementing a community-based school program could enable clinicians to reverse 
childhood obesity among these children (Hoelscher et al., 2012). This study attested to 
the importance of involving the community and its members into the program to gain 
adequate understanding that could outline a childhood obesity prevention plan in the 
areas in question. Because community involvement was significant to understanding and 
improving the health conditions of these children, Heron and Reason’s advocacy 
worldview/participatory framework worked for this study. By conducting collaborative 
research “with” their participants rather than solely “on” their participants, Hoelscher et 
al. were able to acquire pertinent answers and apply them for the improvement of the 
environment in which these children live and their well-being. 
This framework was also appropriate for my study because I wanted to 
understand the lived experiences of people 50+ living with HIV by engaging the 
participants and using the obtained information to improve their social living conditions. 
As Heron and Reason (1997) stated, the participatory/advocacy worldview uses 
knowledge gathered from experience to improve the quality of life of those involved in 





needs of baby boomers living with HIV could be applied to outlining policies and 
programs that could improve the quality of life of this population. 
Theme 1: Increased Life Expectancy of People Living with HIV. 
The mortality rate of older HIV patients has decreased over the years, especially 
since the use of ART. HIV, once a death sentence, is now as manageable as any other 
chronic disease if the treatment is initiated and maintained; in fact, 50% of individuals 50 
years old or older are living with the virus in the United States. (Adekeye et al., 2012). 
The introduction of antiretroviral therapy in the 1990s has increased life expectancy of 
people older than 50 living with HIV (Negin, Mills et al., 2012), which is encouraging as 
it shows the success of ART in treating HIV patients. Rueda et al. (2014) reported that 
the survival rate of HIV infected individuals is continuing to increase. Samji et al. (2013) 
and Deeks et al. (2013) noted that, especially with the advancement of HIV research, life 
expectancy is expected to increase even more over the next decade. However, as science 
continues to prolong the life expectancy of those with HIV, new challenges associated 
with normal aging and use of ART are expected to arise and should be addressed.   
Although Rueda et al. (2014) and Samji et al. (2013) both showed an expected 
increase in survival rates among HIV patients older than 50, their methods differed; 
Rueda et al reviewed the current literature while Samji et al. conducted a 7-year study. 
Rueda et al.’s purpose was outlining results of studies focusing on psychosocial 
challenges of aging with HIV, but Samji et al.’s goal was estimating potential changes in 





et al. searched through 13 national and international electronic databases but only limited 
such search to databases written in English; they reviewed articles that were of 
qualitative, quantitative, or mixed nature that pertained to participants 50 years old or 
older. By contrast, Samji et al. collected their data from a regional AIDS cohort database 
sponsored by NIH, obtaining estimates of life expectancy from mortality rates from the 
cohort design of HIV infected individuals in Northern America and Canada. Samji et al. 
focused on a population of 20-year-old Americans and Canadians, which they followed 
for 7 years while calculating what their life expectancy would most likely be at 70 years 
of age should they remain on ART. One issue with the study was that the sample size of 
82,000 subjects was not an adequate representation of the population of both Canada and 
the United States (Samji et al., 2013). Another issue was that the authors did not outline 
what challenges or side effects if any, would these participants encounter over time, 
which supports the need for the current study.  
As opposed to younger populations with HIV, older populations living with HIV 
are more prone to comorbidities (Rueda et al., 2014). Rueda et al. found that in the 
United States, 94% of HIV patients over 50 have at least three comorbidities such as 
hypertension, diabetes, coronary heart disease, or major depressive disorder. For older 
HIV patients, this multimorbidity was coupled with decreased physical functioning 
(Rueda et al., 2014). This decrease could affect their day-to-day activities, making them 
in need of social support. Although having at least one comorbidity was common, Rueda 





lower among males. This could suggest that socioeconomic factors affect ease of access 
to HIV services and that men could have other means of coping with their condition. 
Lastly, gay and bisexual men had a lower incidence of depressive disorders as well as 
better quality of life than heterosexuals; which the authors attributed to the presence of 
supportive programs (Rueda et al., 2014). In other words, there is a lack of social support 
for the heterosexual HIV population that has resulted in a higher incidence of depression.  
The use of ART has been shown to increase the projected life expectancy of those 
with HIV. Samji et al. (2013) reported that life expectancy of their participants increased 
over time from 36.1 years in 2000 to 51.4 years in 2007 with a standard error of 0.5. 
Using intravenous drugs, being of African American decent, and having a CD4 < 350 
cells/mm3 were significant risk factors to a lower life expectancy (Samji et al., 2013). 
This could suggest that minorities have poorer chances of survival than their counterparts 
due to lack of access to the health care system in general. Additionally, women were 
noted to have a higher life expectancy than males, which the authors attributed to women 
accessing health services more than their counterparts (Samji et al., 2013). They 
concluded that if diagnosed and placed on ART early on, an individual could be expected 
to live up to 70, significantly reducing the mortality rate. Overall, Rueda et al. (2014) and 
Samji et al. reported an increased life expectancy with use of ART, almost always a 
presence of depression, decreased physical function, and lack of social support.  
Despite the positive implications of these studies, there needs to be additional 





gain further understanding of this population’s experiences not only when aging with the 
virus but also factors that could influence their psychosocial well-being (Rueda et al., 
2014). Qualitative studies focusing on the lived experiences of aging patients with HIV 
would not only increase understanding of this group but also contribute to policy 
planning (Rueda et al., 2014). Samji et al. (2013) also noted that several factors affecting 
life expectancy of HIV individuals over 50 ought to be further investigated to tailor 
appropriate health services, which was one of the intents of my study.  
As the rate of HIV infection among people 50+ increases, so does the onset of 
chronic diseases. Negin, Martiniuk et al. (2012) showed that the incidence of HIV 
infected baby boomers is expected to nearly double, from 9% to 17% by the year 2040, 
while Deeks et al. (2013) estimated the number of infected HIV individuals 50+ to triple 
to 9 million by 2040. In other words, there is a need to follow the life span of this 
population to identify any potential complications that may arise to address them in a 
timely fashion. Vance, Mugavero, Willig, Raper, and Saag (2011) and Kim et al. (2012) 
showed that not only will the use of antiretroviral therapy continue to prolong the life of 
infected HIV individuals 50+, it will also lead to the onset of comorbidities. There have 
been few studies addressing the impact of these comorbidities on the lives of HIV 
patients over 50.  
Despite a lack of studies on the impact of these comorbidities, researchers have 
looked at older individuals with HIV and potential comorbidities. Negin, Martiniuk et al. 





years old or older as well as comorbidities arising from such prolonged life expectancy. 
Kim et al. (2012) also conducted a similar study, assessing a possible correlation between 
obesity and multimorbidity among HIV patients. Negin, Martiniuk et al. conducted a 
cross sectional study using a self-reported questionnaire with participants 50 years older 
with a cohort of participants aged 18-49 for comparison purposes; however, the 
challenges of those in a 18-49-year-old cohort may not be representative of challenges 
experienced by people 50+ living with HIV. Vance et al. (2011) also conducted a cross 
sectional study where they reviewed roughly 14,000 electronic medical records on HIV 
patients who attended an HIV clinic to better assess any patterns of comorbidities that 
would arise (Vance et al., 2011).  
Negin, Martiniuk et al. (2012) showed an association between HIV and 
comorbidities in older populations, such as rates of hypertension, as opposed to the 
cohort of participants aged 18-49. However, they noted that despite numerous studies 
showing a correlation between living with HIV and multiple comorbidities, they could 
not find any other comorbidity besides arthritis and hypertension in their study (Negin, 
Martiniuk et al., 2012). Since the cohort group aged 18 to 49 is hardly composed of an 
older population, the above results cannot easily be generalized to the appropriate 
population of individuals over 50 diagnosed and treated for a longer period of time.  
Vance et al. (2011) reported that the older the patients, the more likely they were 
to have been diagnosed with HIV a long time ago, and the more likely they were to have 





suggest that people 50+ living with HIV are not only at risk for side effects of ART, they 
could also be at risk for side effects of the medications treating their newly diagnosed 
chronic diseases. However, based on their study, it is not clear whether the onset of newly 
diagnosed comorbidities results from long-term use of ART, old age, or a combination of 
both. Like Negin, Martiniuk et al. (2012), Kim et al. (2012) showed a statistical 
significance in terms of multimorbidity among older HIV patients on ART (Kim et al., 
2012). This means that this multimorbidity could be the next major challenge replacing 
the old challenge of being diagnosed with HIV decades ago.  
In terms of limitations, Kim et al. (2012) stressed the inability to generalize the 
overall results because the data was obtained at one clinic rather than at several sites. By 
contrast, Negin, Martiniuk et al. (2012) reported their limitations to be associated with 
self-reporting of data. The overall response rate estimated at 76% was due to failure of 
more participants over 50 years to consent to the study (Negin, Martiniuk et al., 2012). 
This raises a concern for my research on HIV among people 50+, a sensitive topic for 
those living with the virus for various reasons including but not limited to stigma and 
lack of social support.   
Negin, Martiniuk et al. (2012) showed the need to focus on HIV individuals over 
50 taking ART to better assess their length on the medication, which could influence the 
incidence and prevalence of comorbidities possibly associated with both living with the 
virus and being on triple antiretroviral therapy (Negin, Martiniuk et al., 2012). 





initiation of ART to assess how well they respond to the medication over time and 
address any side effects and/or complications that may arise. Negin, Martiniuk et al. also 
stressed the need for integration of care on multimorbidity among this age group. The 
authors could be implying that general healthcare providers and HIV specialists should 
work together to better serve this population. Essentially, healthcare associates should 
address the challenges of these patients to appropriately assess the side effects of their 
poly-pharmacy in order to, adjust their medications accordingly.  
Vance et al. (2011) stressed the importance of nurses understanding the different 
comorbidities, i.e., hypertension, heart diseases that HIV patients over 50 face as they are 
living longer with the virus. To Vance et al., such understanding could be instrumental to 
ensure healthcare providers better treat their patients (Vance et al., 2011). Being 
knowledgeable about the various chronic diseases HIV patients face is as important as 
being knowledgeable about the side effects and interactions of the medications they are 
on, as well as how it affects their lives as a whole. As such, understanding the lived 
experiences of these participants could benefit clinicians as well as policy makers in 
making impactful changes. Lastly,Vance et al. stressed the great need for policies that 
would focus on funding the treatment of HIV patients over 50 living with various 
comorbidities, especially as the life expectancy is ascending (Vance et al., 2011). Kim et 
al. (2012) stressed the need for scientists to focus on guidelines pertaining to the impact 





clinicians could make informed decisions that would benefit this population (Kim et al., 
2012).   
As opposed to Vance et al. (2011) and Kim et al. (2012), Negin, Martiniuk et al. 
(2012) did not find any evidence of depression among their participants. Nonetheless, all 
authors did find increased life expectancy and increased incidence of multi comorbidities 
when aging with HIV and using ART. However, the authors did not outline a possibility 
that the type of comorbidities that arose among certain patients might be dependent on 
specific risk factors such as years of HIV diagnosis, years on ART, or poly pharmacy as I 
explored in my study.   
Theme 2: Onset of Comorbidities  
The introduction of ART has prolonged the longevity of people 50+ living with 
HIV; however, it has presented new challenges in forms of chronic diseases. Rueda et al. 
(2014) and Negin, Martiniuk et al. (2012) stressed that onset of comorbidities were 
higher in this older population on ART than among their counterpart not on ART (Rueda 
et al., 2014; Negin, Martiniuk et al., 2012). This, although unclear, may imply that being 
on ART is more of a culprit to early onset of chronic diseases than older age. Rueda et al. 
added that at least 94% of HIV infected individuals over 50 that are on ART presented 
with at least one comorbidity, with the majority presenting with at least three (Rueda et 
al., 2014). This percentage is devastating because it implies that not only is being on ART 
a risk factor to early onset of chronic diseases, it is now a major risk factor to both 





an increased onset of comorbidities, they outlined that only 29.6% of people over 50 
presented with two or more comorbidities (Negin, Martiniuk et al., 2012). Deeks et al. 
(2013) showed that in the United States, there is a 1.5 fold increased risk of people 50+ 
developing at least one comorbidity when on ART (Deeks et al., 2013). This outlines that 
older HIV patients, although on ART, are becoming sicker than anticipated decades ago. 
Each chronic disease they face has a different effect on their body and knowing how they 
are affected on a daily basis is crucial for healthcare providers to tackle each challenge as 
it arises.  
Oursler et al. (2011) conducted a cross sectional study to assess a possible 
association between age and comorbidity with physical function between HIV patients 
and non-HIV patients. They enrolled HIV participants being followed for various chronic 
issues across eight VA centers and clinics (Oursler et al., 2011). On the other hand, Liu et 
al. (2014) conducted a study to assess depression and quality of life of young (18-49) and 
older (> 50) participants living with HIV in China for comparison purposes. Participants 
were selected from a health center where they had received proper HIV care and 
treatment (Liu et al., 2014). 
As stated above, the older and the more prone to chronic diseases someone 
becomes, the more impact could be noted on a physical body level. Oursler et al. (2011) 
reported a significant decline of physical function among HIV patients older than 55 (p < 
0.001) as opposed to their counterparts who were not infected. This could suggest that the 





daily living. Ourlser et al. added that although having a history of cardiac disease was a 
predictor of poor physical function, the latter was worsened in a patient with a history of 
hypertension. A 50-year-old HIV patient with noted comorbidity showed a physical 
function level of a 68-year-old uninfected patient with no noted comorbidity (Oursler et 
al., 2011). In other words, old age and presence of comorbidities in HIV patients 
worsened their health condition as compared to the general population. Oursler et al. 
concluded that age associated comorbidities do affect physical function in HIV patients.  
Similar to Oursler et al. (2011), Liu et al. (2014) reported that the older the HIV 
patient was, the lower the level of well-being, the higher the level of depression, and the 
poorer the quality of life; which they attributed to low physical health and ongoing 
psychological challenges. The above findings may imply that as this population ages with 
the virus and as other diseases and challenges arise, they become unable to physically 
care for themselves and experience a depressive state. This ultimately outlines the greater 
need for programs that would ease this transition and provide interventions for them to 
improve their quality of life. Additionally, Liu et al. reported that 74.2% of older HIV 
patients were depressed as opposed to 48.7% of younger HIV patients. This gap in 
percentage might suggest that older HIV patients encounter more challenges than their 
counterparts, which need to be identified and addressed. Social interactions were lower 
among older HIV patients as opposed to their counterparts; and as the level of depression 
progressively increased, the level of well-being and physical health further declined (Liu 





support from their family or their community plays a major role in high level of 
depressive state in older HIV patients.  
The above authors also both reported an increased onset of comorbidities among 
aging HIV patients on ART, as well as higher level of depressive behaviors, and lower 
level of physical function. However, they failed to address whether such depressive mood 
is a result of aging with HIV, aging with the comorbidities that develops, or lack of 
family social support. In addition, they did not address whether the noted decreased in 
physicality is due to the side effects of poly pharmacy from multi comorbidities, side 
effects of ART, or simply aging. 
 As state above, living with HIV and being on treatment leads to multiple chronic 
diseases especially for the aging population. Multimorbidity, defined as the onset of two 
or more chronic diseases, is present in 65% of HIV infected patients on ART (Kim et al., 
2012). Guaraldi et al. (2011) addressed that aging with HIV contributes to a 3 to 15 times 
higher comorbidities related mortality (Guaraldi et al., 2011). Similar to Guaraldi et al., 
Vance et al. (2011) added that aging with the virus coupled with use of ART would 
simply continue to increase the prevalence of comorbidities in that group (Vance et al., 
2011). This suggests that both age and use of ART are associated with onset of chronic 
diseases in the HIV patient. Both Rueda et al. (2014) and Negin et al. (2010) also 
addressed this complex phenomenon of aging with HIV and the need for adequate 






Guaraldi et al. (2011) compared infected and non-infected HIV patients in terms 
of onset of comorbidities. They reported that specific age related chronic diseases were 
noted among HIV patients older than 50 (Guaraldi et al., 2011). This association between 
age and onset of comorbidities in the older HIV patient align with findings of Oursler et 
al. (2011). Guaraldi et al. further reported that individual prevalence of multi morbidity 
(≥ 2 noninfectious comorbidities) were significantly higher among HIV patients as 
compared to control patients (p < 0.01). They also illustrated that prolonged ART 
exposure were statistically significant predictors of multi-morbidity; suggesting the need 
for these comorbidities to be screened early on for HIV patients to be treated 
appropriately (Guaraldi et al., 2014). In fact, 40-year-old HIV patients were noted to have 
risk factors similar to that of 55-year-old un-infected patients (Guaraldi et al., 2014). The 
above implies that early onset of chronic diseases among HIV patients may precipitate 
the ‘normal’ process of aging.  
Vance et al. (2012) reported that as HIV patients’ viral load decreased, the 
prevalence of comorbidities increased, and so was the number of medications they were 
taking for treating their comorbidities. These comorbidities including but not limited to 
hypertension, diabetes, and coronary artery disease were the most commonly seen (Vance 
et al., 2012). The above findings might suggest that the authors’ population sample was 
mainly obese since it is a major risk factor for the comorbidities outlined. They also 





counterparts (Vance et al., 2012). These findings were consistent with those of Negin, 
Martiniuk et al. (2012) and Guaraldi et al. (2011).  
In their study, Burgess et al. (2015) showed that as opposed to non-infected 
patients, older HIV patients already have several comorbidities including major 
depression, and thus the choice of ART should be carefully considered since some ART 
medications are contraindicated in uncontrolled depressive disorders (Burgess et al, 
2015). These findings align with those of Liu et al. (2014). This suggests that careful 
attention is needed when treating HIV patients in order to appropriately identify possible 
drug interactions, adjusting dosages, and/or switching the medications as needed. 
Additionally, Burgess et al. noted that in the United States, the onset of cardiovascular 
diseases was noted at a much younger age among HIV patients than non-infected ones. 
The latter was due to un-treated HIV infection in some and the adverse effect of 
prolonged ART use in others (Burgess et al., 2015). The authors are implying that, as 
with any comorbidity, side effects are noted from either not starting ART treatment in a 
timely fashion or from medication used to treat the condition in question. They concluded 
that because of the risk of drug related complications; early screening is necessary for 
appropriate choice of ART (Burgess et al., 2015).  
The above authors reported a similar consensus of increased multi comorbidities 
among aging HIV patients, with depression and hypertension almost always present. 
However, they reported a strong predictor of even higher onset of comorbidities among 





to ensuring they seek appropriate HIV care whether or not they might lack social support. 
As such my research geared towards understanding the lived experiences of people over 
50 and the challenges that may develop is of value.  
Theme 3: Limited Access to Health Services  
With the onset of comorbidities, adequate routine healthcare access for people 
over 50 living with HIV is paramount. However, the literature shows a very scarce access 
to such services (Guaraldi et al., 2011). Not only is this suggesting a continued increased 
number of un-diagnosed chronic diseases among HIV patients, but it also suggest un-
addressed factors preventing such access, and/or lack of services to meet the demands of 
this group. Patel et al. (2016) addressed this high incidence of HIV infected patients over 
50 with multiple untreated comorbidities, which they attributed to the use of clinics not 
equipped with properly trained HIV personnel (Patel et al., 2016). Mugavero, Amico, 
Horn, and Thompson (2013) noted that although the introduction of ART has prolonged 
the life expectancy of people over 50 living with HIV, most patients still lacks adequate 
access to the HIV care (Mugavero et al., 2013). In addition, they outlined the need for 
public health lawmakers to create policies that would strengthen better monitoring of this 
population living with HIV as well as tailoring interventions that would encompass both 
the clinical and community-based aspect (Mugavero et al., 2013).  
Patel et al. (2016) showed the relationship between onset of comorbidities and 
length of diagnosis with HIV (Patel et al., 2016). Such association suggests the utmost 





arise from both the virus itself and its treatment. Patel et al. outlined that years living with 
the virus and use of ART were significant predictors of onset of comorbidities among this 
older population. In addition, they reported that at least 84% of HIV patients over 50 had 
more than one comorbidity while 61% reported more than two. Among these 
comorbidities, they outlined depression, hypertension, and hypercholesterolemia as the 
most commonly encountered. They also reported that limited or no access to health 
services was directly correlated to the increased onset of multimorbidity seen among this 
group. As such they recommended a need for researchers to focus on examining patients’ 
access and experience to health care services (Patel et al., 2016).  
Although Mugavero et al. (2013) reported that half of HIV individuals over 50 
lack access to HIV care, Patel et al. (2016) reported that with more than half having at 
least two comorbidities, some lacked access while others failed to be retained for follow 
up (Mugavero et al., 2013; Patel et al., 2016). As stated above, there is a certain level of 
complexity involved when treating an older patient living with HIV, diagnosed with 
depression, and other multi comorbidities. However, the authors failed to outline such 
complexity as possible reason behind this lack of adequate health support. Also, there is 
the possibility that family social neglect plays a part in this population being too 
overwhelmed and thus unable to seek care and follow up. In addition, there is a 
possibility of this population perceiving that clinicians might not address their needs due 





Moreover, there could be a possibility of this group simply not being aware of the 
presence of services that could address their needs.  
Access to healthcare services remain of high importance for HIV patients not only 
for initial diagnosis but also for long-term care. Samji et al. (2013) outlined that despite 
ART associated prolonged longevity, there is still a sizable difference in mortality 
between patients who have adequate HIV care access and those who lack such access 
(Samji et al., 2013). Deeks et al. (2013) also outlined this weak delivery of care for HIV 
infected patients, stressing that access to appropriate care and retention in care is key 
(Deeks et al., 2013). Unfortunately, in the United States, only about a third of HIV 
patients have access to an adequate HIV system (Deeks et al., 2013). There is a major 
lack of a proper system and lack of healthcare providers to care for infected HIV 
individuals over 50 facing multimorbidity issues (Cahil & Valadez, 2013). As infected 
HIV people over 50 continue to age and continue to lack access to services addressing 
their needs, the challenges they face daily will simply worsen.  
Based on their results noted above, Samji et al. (2013) recommended that 
researchers and lawmakers focus on policies that could improve health outcomes of 
people over 50 living with the virus (Samji et al., 2013). In addition, since their research 
showed that such life expectancy is subject to increase over the next decade, they stressed 
that further studies focus on improving the current quality of life of this population 
(Samji et al., 2013).  To design appropriate services that would improve their current 





such, Rabkin, Kruk, and El-Sadr (2012) similarly reported that early screening, 
psychosocial support, and HIV treatment facilities are needed for older HIV patients, 
already at risk for side effects of poly pharmacy (Rabkin, Kruk, & El-Sadr, 2012).  
Although the authors reported increased mortality among HIV patients and 
increased lack of access to adequate HIV care, they failed to outline the possibility that 
HIV individuals over 50 lack awareness of the negative impact of being on ART, aging 
with the virus, and the comorbidities that arise; thus lack awareness of the importance of 
seeking and following up care. Additionally, they did not outline the possibility that the 
public heath sector might not yet fully be equipped to keep up with the demand of the 
growing population of individuals over 50 aging with HIV and multi comorbidities. 
Research geared towards addressing such lack of awareness and challenges is of 
necessity to properly outline a program that could address their needs. In conducting my 
study, questions pertaining to the aforementioned awareness or lack of awareness were 
investigated when interviewing the participants.  
Theme 4: Unaddressed Psychosocial Issues  
The limited access to healthcare is not only leading to unaddressed comorbidities 
but also to psychosocial issues among HIV patients over 50. Kim et al. (2012) outlined a 
series of multi morbidities categorized under metabolic, behavioral, and substance use 
(Kim et al., 2012). Brennan et al. (2011) noted evidence of not only psychosocial issues 
such as depression and stigma but also neglect among people over 50 living with HIV 





immediate communities. In addition, it could further suggest that they feel misunderstood 
by the healthcare system failing to address their needs. Sankar et al. (2011) also noted 
that while 25% of HIV patients over 50 showed signs of moderate depression due to 
overall poor physical health and lack of social support; 39% could be diagnosed with 
major depressive symptoms due to isolation and lack of social support (Sankar et al., 
2011). This high percentage suggests that access to social services could reduce this level 
of depression.   
In their study, Kim et al. (2012) assessed predictors of multimorbidity and 
identified hypertension, diabetes, chronic kidney disease, hyperlipidemia, and depression 
as major comorbidities (Kim et al., 2012). This finding of chronic kidney disease was 
interesting, as previous authors did not note that. In fact, most medications are filtered by 
the kidneys, which as we age decline in function. One would expect to see that process 
worsen in an older HIV patient with poly pharmacy. Kim et al. also outlined that obesity 
was correlated to higher increased incidence of multimorbidity (Kim et al., 2012) 
Brennen et al. (2011) recommendations where centered on the need for future 
research to focus on the psychosocial need of elderly living with HIV. Additionally,, they 
outlined the lack of current research pertaining to the need of such population and the 
impact such research would have. Lastly, they stressed that more insight into the current 
social system is needed to better the overall lifestyles of the population in question 
(Brennen et al., 2011). Similar to Brennen et al., Sankar et al. (2011) recommended a 





HIV, the social stigma they endure, and also for researchers to focus on the complexity of 
aging with HIV and the comorbidities that develop (Sankar et al., 2011).  
Although Brennen et al. (2011), Sankar et al. (2011), and Kim et al. (2012) 
similarly reported depressive behaviors partly due to social stigma, isolation, or neglect to 
be common, they failed to outline the reasons behind the limited access to HIV care 
(Brennen et al., 2011; Sankar et al., 2011; Kim et al., 2012). On the other hand, Sankar et 
al. pointed out a higher level of low social support among minorities and reluctance of 
undiagnosed HIV individuals over 50 to learn about risks associated with HIV (Sankar et 
al., 2011). This could show that uninfected people over 50 simply lack awareness of the 
true risks associated with HIV, and since fearing social isolation from their respective 
families choose not to be tested. Additionally, those infected may simply not be aware of 
the possible negative impact of aging with the combination of HIV and depression. As 
such my research geared towards examining such impact could assist in improving their 
quality of life. 
Theme 5: Lack of Policies and Heath Care Services  
Tailoring adequate policies are essential to improving the quality of life of people 
over 50 living with HIV. Brennen et al. (2011) shared that no policies have been outlined 
to address the issues of this aging population due to lack of basic knowledge surrounding 
their needs (Brennen et al., 2011). For public health lawmakers to outline a program that 
could meet the current needs of this population while being successful, a clear 





needs of this group are not met due to a lack of knowledge of their experiences as it 
pertains to access to care (Patel et al., 2016). Cahil and Valadez (2013) reported that the 
lack of policies addressing this population’s issues and needs is preventing improvement 
of their current quality of life (Cahil & Valadez, 2013). There is a pressing need for this 
group’s issues to be researched and properly addressed (Deeks et al., 2013).  
Patel et al. (2016) conducted a cross sectional study to measure participants’ 
lifestyle, access to healthcare, diagnosed chronic diseases, as well as medications 
throughout their journey living with HIV. Based on their results, they showed an 
association between using healthcare services not equipped with qualified HIV personnel 
and increased comorbidities (Patel et al., 2016). Non HIV specialists may not be as 
familiar with side effects and cross interactions of specific HIV medication with 
medication used to treat chronic diseases. This could suggest that patients being initially 
treated and followed by HIV specialists are more likely to have a better prognosis than 
those being treated by generalists. These findings stress the importance of access to HIV 
healthcare services to meet the need of that growing HIV population (Patel et al., 2016). 
It was necessary through my research that I gained an adequate understanding in regard 
to not only whether or not my subjects have adequate access to HIV care services, but 
also whether or not they feel that their needs are met.  
Brennen et al. (2011) similarly recommended that more healthcare centers be 
implemented and more HIV specialists be adequately trained. They found that the lack of 





that appropriate emotional support should be provided to both the affected patients and 
their respective families (Brennen et al., 2011).  
While Brennen et al. (2011), Patel et al. (2016), and Cahil et al. (2013) all came to 
a similar conclusion that there is a lack of policies addressing the “needs” and/or “issues” 
of the aging HIV patient, they similarly reported that this population faces challenges 
associated with aging with the HIV virus (Brennen et al, 2011; Patel et al., 2016; Cahil et 
al., 2013). However, they failed to outline what the challenges and issues are. They also 
failed to consider the possibility of absence of awareness of the negative impact of aging 
with HIV, from the patient and the clinician standpoint. People over 50, already 
stigmatized by their community and family members for being HIV positive, could 
possibly show reluctance in seeking proper HIV care for fear of being yet again 
stigmatized by clinicians. Or, due to their lack of social support, they could simply lack 
the physicality to transport themselves to the doctors.  
As with living with any disease, there are several negative effects of living and 
aging with HIV. This could only be adequately understood from these patients’ 
perspective. As such, in order for clinicians and public health practitioners to properly 
address the needs of this population and for lawmakers to outline policies specifically 
tailored to this group, proper understanding of their lived experiences and challenges is 
paramount. The overall results of my study could provide clinicians with evidence that 





with enough information to outline appropriate policies that could improve their quality 
of life.  
Conclusion 
Overall the literature shows that people over 50 living with HIV face several 
challenges from onset of multimorbidity, to psychosocial issues, to lack of appropriate 
access to care addressing their needs (Guaraldi et al., 2011). With the number of 
individuals in that group continuingly ascending, there is a great need for a better 
understanding of their experiences so that tailored policies and health care systems 
focusing not only on access but also retention be developed (Mugavero et al., 2013). The 






Chapter 3: Methodology 
The purpose of this phenomenological study was to understand the lived 
experiences of people older than 50 living with HIV to address their challenges and 
improve their quality of life. In this chapter I will report information on the research 
design and rationale, the role of the researcher, the step-by-step methodology, and the 
issues of trustworthiness or credibility. This chapter will conclude with an overall 
summary of the chosen methods for this study.  
Research Design and Rationale 
I sought to answer the following questions: What are the experiences of people 
50+ living with HIV? How do people 50+ describe their experiences with HIV? How do 
HIV-positive patients older than 50 describe the challenge of living with HIV and newly 
diagnosed comorbidities?  
I used phenomenology to assess the lived experiences of people living with HIV. I 
attempted to identify participants’ experiences, and understand these experiences and 
how they affected the participants, so I could outline ways that could improve their 
quality of life. To answer my research questions, I chose a qualitative research approach. 
Creswell (2009) identified five types of qualitative research: ethnography, grounded 
theory, case study, phenomenal, and narrative research. Researchers choose one of these 
types of research depending on the purpose of their study.  
When choosing ethnography as a research design, the researcher studies an intact 





time. During that study period, observational as well as interview data are collected. The 
main idea is to capture the lived realities of those participants within their natural setting 
(Creswell, 2009). This design was not suited for my study which purpose was to 
understand lived experiences based on a specific phenomenon rather than studying 
cultural groups. Grounded theory is used when researchers generalize an abstract theory 
of an action based on the view of the participants. During that study process, data is 
collected at various stages. Creswell (2009) outlined that to maximize similarities and 
differences among different groups within the study, researchers rely on constant 
comparison of data with sampling of different groups, which is unique to this theory. This 
design was not suited for my study as I was seeking to assess and describe characteristics 
of individuals sharing a similar phenomenon rather than looking at different groups. Case 
studies are often used when researchers explore a program, process, or simply 
individuals. In doing so, detailed information pertaining to the participants is collected 
over a specific period of time (Creswell, 2009). This design was not suited for my study 
because I was not seeking to observe a particular behavior nor understand a given 
phenomenon; instead, I was seeking to assess experiences of individuals pertaining to a 
specific phenomenon. Narrative research involves the researcher studying the lives of the 
participants while asking them to provide detailed stories about it. Eventually, the 
collected story line is retold into a narrative form by the researcher, specifically 
combining both the participants and researcher’s view (Creswell, 2009). This design was 





lives; instead, I was interested about their living experiences pertaining to a specific 
phenomenon. 
In a phenomenological approach, the researcher identifies human experiences 
pertaining to a specific phenomenon described by the participants (Creswell, 2009). The 
researcher aspires to understand the lived experiences of the involved participants over an 
extended period of time, which allows patterns to form. In this approach, researchers 
disregard their own experiences to focus on understanding the participants’ experiences 
(Creswell, 2009). Husserl, the fountainhead of phenomenology of the 20th century, 
reported that individuals are usually certain about things that happen to them, which 
means all that happens outside of their immediate experience ought to be excluded 
(Groenewald, 2015). Based on Husserl’s belief that reality must be treated as pure 
phenomenon, data collection should begin at the source to keep the data as accurate as 
possible (Groenewald, 2015). In other words, data should be collected from the 
individuals that experienced the phenomenon in question.  
This study’s phenomenon was the experience of people 50+ living with HIV and 
comorbidities. The intent of my research was to understand, from the participants’ 
perspective, the experience of living with HIV as an individual older than 50. By 
obtaining detailed information of these experiences from participants, I aimed to draw 
conclusions that could be effective in improving their quality of life as well as that of 





phenomena and collected data from their descriptions of these experiences, the 
phenomenological approach was appropriate for my research. 
Role of the Researcher  
My role as a researcher in this study was to ask a series of open-ended questions 
through a recorded telephone interview to gain an understanding of participants’ 
experiences. Throughout the interview, I engaged with my participants as they described 
their experiences, enabling me to see through their perspectives. Finally, as the main 
researcher, I was involved in all aspects of the study from defining the concept of the 
study to collecting, transcribing, and analyzing the results. 
Having a known relationship with the participants could create potential bias. I 
did not have pre-established personal relationship with my participants and did not 
purposefully include participants in the study based on my relationship with them. I used 
a pre-outline inclusion and exclusion criteria to select my participants. Additional bias 
could appear when the researcher introduces an error by selecting particular data 
collection or outcomes (Pannucci & Wilkins, 2010). I addressed this by remaining 
objective and mindful of my interpretations of participants’ experiences. Although it was 
important to establish a professional relationship with the participants, I was mindful of 
bias that could arise such as misinterpretations (Sanjari et al., 2014). 
Just like bias, ethical issues may have occurred throughout the study. Because my 
research is centered on a sensitive topic which some are not even yet comfortable 





names of participants. In dealing with sensitive topics involving vulnerable individuals, 
Sanjari et al. (2014) recommended having an advocate present during the interview 
process; however, this was not necessary as my participants were fairly comfortable in 
sharing their experiences.  
I recruited participants through a local HIV care clinic as well as through online 
HIV groups. I did not have an already built relationship with my participants and did not 
conduct the study in my own professional environment, which avoided any potential 
conflict of interest. In recruiting participants from an HIV agency and an online HIV 
community, I offered participants an incentive in the form of a gift card, which the IRB 
approved. 
Methodology 
Participant Selection Logic 
Participants for this study were individuals 50 years old or older living with HIV 
for at least 20 years and those with at least one comorbidity since their diagnosis. I used 
purposeful sampling in recruiting participants from a local HIV clinic where they 
normally received treatment. Purposeful sampling is a type of sampling in which 
participants are intentionally selected for the study to outline specific predefined 
characteristic they have which, are essential in understanding the phenomenon being 
studied (Luborsky & Rubinstein, 1995). Participants were only be selected if they had a 
connection to the phenomenon. Since my phenomenon was the experience of people 50+ 





provide adequate insight on their experience of living with the virus as well as 
complications that may developed from it. Participants were included in the study 
regardless of their race, gender, social economic status, and sexual orientation. The most 
important inclusion factors were being 50 years old or older, living with HIV for at least 
20 years, being on ART, and having at least one comorbidity. Newly diagnosed HIV 
patients were excluded from the study.  
Determining sample size is another important factor in research, and researchers 
need to be careful not to have too small or too large of a sample (O’Reilly & Parker, 
2012). A larger sample could lead to sampling errors, which could affect the results 
(Marshall, 1996). The choice of sample size depends on the parameters of the 
phenomenon being studied (Marshall, 1996). In qualitative research, the sample size 
tends to be smaller than it would be for quantitative study since the scientist is more 
concerned with the meaning as supposed to the quantity (Manson, 2010). With a 
phenomenology design, using a small number of participants is beneficial, as it prevents a 
large sample that produces repetitive data (Manson, 2010). I planned to study up to 25 
participants to ensure saturation is met. Data saturation is reached once additional 
interviews no longer yield new information and when further coding is no longer feasible 
(Bonde, 2013; Fusch & Ness, 2016; Sargeant, 2012). To adequately assess that saturation 
is reached, Sargeant (2012) recommended documenting new themes as they emerge 
throughout the interview. Failure to adequately attain saturation can negatively affect the 





There are several types of saturation used in qualitative research: theoretical, data, 
and thematic saturation (O’Reilly & Parker, 2012). With thematic or data saturation, the 
scientist should continuously collect information until no new information emerges. 
Theoretical saturation occurs when the scientist notes that all the involved categories are 
accounted for, but that variability may also exist between the outlined categories 
(O’Reilly & Parker, 2012). In my study, I used data saturation (through data analysis) and 
thematic saturation (through theme analysis). I recorded new data throughout the 
interview and placed them into thematic patterns. Once no new thematic patterns 
emerged, I determined saturation was met and obtained my sample size.  
Participants who fit the inclusion criteria, who were receiving treatments at the 
agency and those in the online community, were provided with documentation offering 
them the opportunity to participate in the study; if retained for the study, they were 
contacted via their self provided telephone number to schedule their interview. The 
interviews occurred wherever each participant felt comfortable, as they were conducted 
via telephone. The first participants fitting the profile and yielding to saturation were 
retained for the study.  
Instrumentation 
Prior to data collection, I obtained IRB approval (03-07-17-0379944). Each 
participant was required to turn in his or her signed consent and give verbally explain 
their understanding of the signed consent. They were reminded of their right to voluntary 





conducted telephone interviews with the participants, going over a predetermined open-
ended questionnaire, focusing on the participants’ experiences of living with HIV 
including the adverse effects. Throughout the interview, I remained engaged with 
participants by not taking notes and instead recording each session using a digital 
recorder. Once all interviews were complete, a professional transcriptionist completed the 
transcription. I ensured that the transcriptionist turned in a signed confidentiality 
agreement attesting to the privacy of the participants and data.  
Because I used a phenomenological approach, conducting telephone interviews 
helped me gain insight into the experiences of my participants. “Humans” are an 
important “instrument” when conducting qualitative research, as they can directly interact 
with the phenomenon in question within their own environment (Sanjari et al., 2014). 
Researchers should look for biases that are likely to occur from working in these natural 
settings (Sanjari et al., 2014). Kuzmanić (2009) stated that a researcher should assess the 
validity of the data throughout the qualitative interviewing process through proper data 
collection, analysis, interpretation, and transcription. The instrument I used to collect data 
was in-depth semistructured interviews, which is common in qualitative research. In-
depth interviews are essential in getting participants to elaborate their opinions and 
experiences on the topic at hand (Zaharia, Grundey, & Stancu, 2008), meaning an in-
depth interview worked as an instrument to answer my research questions regarding 





focus groups is that participants are typically more relaxed and willing to elaborate on 
sensitive topics (Zaharia, Grundey, & Stancu, 2008).  
Some researchers are inclined to observational qualitative research, with a focus 
on outlining their comments as opposed to sharing those of the subjects; however, 
researchers can use interviews to outline the subjects’ narratives and their shared 
experiences while masking their opinions of the phenomenon at hand (Edwards & 
Holland, 2013). Phenomenologists choose interviews because of their interest in the 
meaning of a specific phenomenon as it is understood and lived by the participants 
(Englander, 2012). To attain this knowledge, an interview should contain questions aimed 
at uncovering and understanding details on the phenomenon in question, such as 
questions that would make it easier for participants to describe, in as much detail as 
possible, anything related to their experience of the phenomenon in question (Agee, 
2009; Englander, 2012). Framing research questions is the essential part of data 
collection in qualitative interview, meaning they should be specific to gather sufficient 
data from the interview (Turner, 2010). Open-ended questions should be used to avoid 
guiding the participants’ answers (Turner, 2010).  
Follow-up questions should pertain to specific details surrounding the 
phenomenon based on answers provided in the initial questions (Englander, 2012). When 
formulating follow-up questions, scientists should ensure they obtain the needed 
information as well as keep participants engaged in the topic at hand (Turner, 2010). 





simple and clear follow-up questions to incite participants to share information on their 
experiences of aging and living with HIV as well as the comorbidities that arise from it. 
These questions were as follows: 
1. Tell me about your experiences living with HIV.  
2. Tell me about the effects HIV has had on your daily life and your relationship 
with family, friends, and coworkers.  
3. Describe your awareness of sexual risks associated with HIV infection.  
4. Tell me about your health care experiences since testing positive for HIV.  
5. What is your knowledge of HIV resources and support programs in your 
community?  
6. What is your experience with those HIV services?  
7. Describe your experience with support from your family or lack of support. 
8. Describe any experiences you might have where friends, family, coworkers, 
or anyone else avoided you because of being HIV positive.  
9. Describe your experience with your local HIV clinic.  
10. Describe your relationship with HIV medical specialists. 
11. Describe your knowledge on follow up of care with HIV specialists when 
living with HIV.  
12. Describe your experience of living with HIV and being on ART. 





14. What is your experience of living with HIV and being on multiple 
medications? 
15. What is your experience of coping with side effects of multiple medications?  
16. Describe whether you believe people have a decline in their health as they 
age.  
17. Describe your knowledge of aging with the HIV virus.  
18. Describe your knowledge of health complications that arise from getting older 
with HIV.  
19. Describe your knowledge on follow up of care with generalists when aging 
with HIV.  
20. Describe your knowledge of side effects of multiple medications used to treat 
complications of old age. 
21. What is your experience of coping with the combination of new comorbidities 
and HIV since diagnosis?  
22. Describe your current quality of life.  
23. Outline factors that could improve your current quality of life. 
Recruitment, Participation, and Data Collection 
I collected data from my participants through individual recorded telephone 
interviews. Data were collected from subjects recruited from an HIV agency and an 
online HIV community. As this is a sensitive topic, I did not have a time limit for the 





sample of up to 10 participants seemed attainable, I recruited more in case some decided 
to drop out. After completion of each interview, participants were thanked for their time, 
participation, and genuine honesty. Their $5 gift card was provided along with additional 
information pertaining to a phone line where they could reach me directly should they 
have further questions regarding the study. Information pertaining to their follow-up 
interviews, scheduled at a later date, was provided as well. An additional $5 gift card was 
provided after the follow-up interview. The follow-up interview was critical to present 
participants with the core themes to attest for the accuracy and appropriate representation 
of their own experiences while giving them an opportunity to comment on them (see 
Creswell, 2009). Participants who dropped out of the study during the initial interview 
phase or the follow-up interview could keep their incentive.  
Data Analysis Plan 
To properly analyze the collected data, Creswell (2009) recommends following 
specific steps as follow, which were helpful in my study. 
1. I analyzed each interview conducted that day, writing notes post interview, 
ensuring I had a specific pre-narrative for my final report. Once the transcriptions were in 
my hand, I read them before adding notes based on the transcribed interviews. 
2. I read through the collected data to get a better understanding of the whole 
picture, capturing the main common points. 
3. Once I completed the above, I put the data into Nvivo software to organize the 





This is called coding and it helped me better understand what each category meant as 
whole.   
4. I later made up specific codes to represent each outlined category while 
assigning it to each segment of the transcribed data.  
5. I then assigned to each group topic, a word that properly described it before 
turning that group into category, checking once more for communality.  
6. Once satisfied with the category name, I alphabetized each code. 
7. I organized the collected data based on the assigned category under the now 
alphabetized code, before beginning the preliminary analysis.  
8. Once satisfied, I grouped the various categories under a broader group called 
“themes” to encompass the main idea at hand.  
For proper data analysis, adequate software should be used; I opted for Nvivo 
software because it has proven adequate for scientists in both evaluating and interpreting 
qualitative texts (Zamawe, 2015). This software was be extremely useful, especially 
considering that my gathered data was from 10 in depth interviews. Had I encountered 
any discrepant cases, I would have included that in my analysis and presented that 
evidence. This serves to maintain my credibility thus validating my study (Creswell, 
2009).  
Issues of Trustworthiness 
In order to assess credibility, also known as internal validity, scientists seek to 





how compatible the results are with actual reality (Shenton, 2004). Used to establish 
credibility, triangulation involves using other methods to gain information on 
participants. In my study, I used interviews as my triangulation method because it 
enabled me to obtain information regarding my participants’ experiences from their own 
perspective. 
To ensure genuine participation and shared experiences, each prospective 
participant was reminded that they have the right to decline participating in the study or 
withdraw at any given point without explanation. I also ensured to make them feel as 
comfortable as possible so they could openly share as much as they felt comfortable 
sharing; which helped maintain the credibility of the collected data. Peer review is always 
important in scholarly work. I welcomed any scrutiny and advice from my committee and 
peers throughout this process. In fact, their non-bias outlook on my project brought up 
fresh ideas that I used to improve my methods and also to avoid jeopardizing the 
credibility of my entire study.  
In addition, I ensured to clearly explain the phenomenon under study so that the 
reader may attest to whether or not the overall results correlate with the underlined 
studied phenomenon (Shenton, 2004). Creswell (2009) recommended using member 
checking to assess the accuracy of the findings. During the follow-up interviews, I 
assessed for accuracy of their reported data to ensure I had an accurate representation of 





Transferability, also known as external validity, is noted when scientists provide 
the reader with enough supporting information on the area of research so that they can 
decide whether the overall findings are credible enough to be applied or replicated 
(Shenton, 2004). In my study, I gathered sufficient data in sufficient depth so that readers 
could get a better understanding of the experiences of people over 50 living with HIV and 
comorbidities; hoping that such knowledge would guide them in making improvements 
in their clinical settings. In addition, I ensured to also provide all parameters pertaining to 
how the study was conducted so they could replicate the study.   
Dependability, also known as reliability, outlines that most researchers use an 
approach similar to that of another so it can be replicated (Creswell, 2009). As stated 
above, I provided the reader with the detailed methodology used in my study, so that it is 
easily replicable in a similar context, using the same methods, and the same type of 
participants. These details should enable another researcher to obtain results similar to 
mine. Even though Shenton (2004) stressed that in phenomenology or qualitative 
research, aspiring to obtain similar results could be a challenge; researchers should at 
least be given the entire methodology so they could attempt to replicate the study. In 
addition, I kept a trail of all documentation used during the process so that it could be 
easily traced back if needed. Shenton describes this process as “audit trail”. To be 
specific, I kept a record of everything I did, whether it seemed important or not, from 
notes I wrote in my journal pertaining to the study, to interviews, and transcription. That 





Confirmability is achieved when scientists successfully take steps to show the 
reader that the presented overall results in fact derive from the collected data and not 
from their own predispositions or interpretations (Shenton, 2004). As such, I remained as 
objective as possible to ensure that I presented information from the participants without 
adding my personal interpretation; I also provided direct quotes from participants. This 
also allowed me to avoid any researcher bias.  
Ethical Procedures 
Prior to reaching out to prospective participants and collecting any data, I needed 
to go through a mandatory approval process for the protection of the participants. To be 
specific, I filled out and submitted my application to the Institutional Review Board 
(IRB), and only once approved did I proceed with data collection. To ensure IRB had a 
better understanding of my anticipated study, I attached my proposal to my application so 
they could make an informed decision. 
IRB ensures that all upcoming scientists, at their respective universities, comply 
with ethical standards and regulations outlined by the federal government. As such, 
Walden’s IRB must approve all submitted proposals before any data is collected (Walden 
University, 2015). Once approval was obtained, I obtained consents from each participant 
and ensured that their physical and emotional being was well maintained. In fact, 
according to IRBs’ guidelines, participants’ human rights should be respected and they 
should not be placed in any physical or emotional risk for the sole gain of the researcher 





their name so that all terms of confidentiality in accordance with the consent were fully 
respected.  
Ethical issues may arise; however, researcher should anticipate them and be ready 
to correct them ahead of time because, maintaining the integrity of the research and thus 
the validity of the results is important. Throughout the study, I always kept my 
participants’ interest first in mind and avoided engaging in any misconduct that would 
have poorly reflected on my committee team, my university, and me. Additional ethical 
issues that may arise with use of incentives when recruiting participants could be seen as 
bribery. To avoid that, I made sure to obtain IRB approval before offering participants a 
gift card thanking them for their time and participation. In addition, although I thought 
that recruitment via the AIDS agency and the online HIV community was adequate, I 
needed to obtain IRB approval before proceeding with that choice.  
Participants were reminded that they could choose not to be included in the study 
and also exit it at any given time shall they wish to do so. For that reason and to maintain 
my sample size, I attempted to recruit up to 15 participants to account for those that could 
exit early but still ended up with my sample size of 10. In addition to recruiting via the 
AIDS agency, I also posted my advertisement for research at various online HIV groups. 
During each interview, I had a back up recorder in case I encounter some mechanical 
failure with one. Once the interview was completed, I transferred the information to a 
personal drop box on my personal computer, which can only be accessed via a password 





drive that I keep in a locked cabinet at my residence. All data pertaining to the study were 
only shared between the transcriber (who signed a confidentiality agreement), my chair, 
and me.  
Summary 
Using a phenomenological approach in conducting this qualitative study was 
essential to better understanding the phenomenon of people over 50 living with HIV and 
comorbidities, as well as the complications that arise from that. As the primary researcher 
in the study, I followed proper ethical guidelines to maintain patients’ privacy, emotional, 
and physical well-being at all times. The data collected through telephone-recorded 
interviews of a small population sample were later transcribed before analysis using 
Nvivo software. The overall findings enabled me to get a better understanding of their 






Chapter 4: Results 
The purpose of this qualitative phenomenological study was to explore the lived 
experiences of participants 50+ living with HIV to gain an understanding of the 
challenges they face as they age with the virus and comorbidities that develop. The 
following RQs guided my study: 
RQ1: What are the experiences of people 50+ living with HIV? 
RQ2: How do people 50+ describe their experiences with HIV? 
RQ3: How do HIV-positive patients older than 50 describe the challenge of living 
with HIV and diagnosed comorbidities?  
In the following chapter, I will outline a description on the settings, participants’ 
demographics, data collection, data analysis, evidence of trustworthiness, and study 
results. I will conclude with an overall summary of the chapter.  
Setting 
I conducted this study via recorded telephone interviews. All participants had 
provided consent to the above in accordance with IRB policies and all agreed to 
participating and being recorded. Scheduling each interview required flexibility; as a 
result, some interviews were conducted on the weekends. There were no personal or 
organizational conditions that appeared to influence the participants that could affect the 






The demographics and characteristics of my 10 participants, presented in Table 1, 
include their age, sex, sexual orientation, number of years living with the virus, and 
number of comorbidities present. All participants met the inclusion criteria of being over 
50 years of age, living with the virus for at least 20 years, living with at least one 
comorbidity, and being on ART. Eighty percent of the participants were homosexual, 
10% were bisexual, and 10% were heterosexual.  
Table 1 
Characteristics of Participants 
Participants 
(P) 




P1 Female 62 Heterosexual 29 6 
P2 Male 60 Homosexual 30 7 
P3 Male 52 Homosexual 21 3 
P4 Male 59 Homosexual 30 7 
P5 Female 65 Bisexual 28 4 
P6 Male 63 Homosexual 27 3 
P7 Male 64 Homosexual 32 7 
P8 Male 51 Homosexual 30 5 
P9  Male 74 Heterosexual 21 1 
P10  Male 55 Homosexual 25 9 
Data Collection 
I recruited 10 participants with whom I conducted and recorded telephone 





process in early March 2017. I mailed a priority sealed and marked “confidential” 
envelope to the head of the AIDS resource agency at which participants received 
treatments. The agency, via their CEO, had approved and agreed to advertise the 
research; I had no part in the recruitment of participants at the facility, hence no access to 
their respective medical records. The mailed envelope contained all necessary documents 
pertaining to the study: 15 approved IRB consent forms, prelabeled and prestamped 
envelopes with my return address for them to return their signed consents form if they 
wished to participate in the study. Within a few weeks, I received two consents back from 
participants, which I reviewed carefully to ensure they met the inclusion criteria before 
calling them to schedule their initial telephone interview. The initial interview was 
roughly 1 hour and 15 minutes. At the end of the interview, participants were reminded 
that, as stated in the consent, they would be contacted in a few days to schedule the 
follow-up interview to attest for accuracy of the collected data. Additionally, the follow-
up interview covered additional questions based on their responses in the initial interview 
to obtain clarifications in certain areas and/or additional details. The follow-up interview 
were roughly 30 minutes.  
The data collection process started on 4/24/17. Each participant was called on the 
day scheduled for the interview. While some were present and ready to proceed, some 
asked if they could reschedule, which I was able to accommodate. Each time I called a 
participant, I re-introduced myself to them, ensuring they knew whom they were talking 





that this would be recorded. They confirmed that they had consented on their own free 
will and were ready to proceed. I recorded each interview session with an audio recorder 
and later transmitted the audio file for transcription to a transcription company bound to a 
confidentiality agreement. Upon obtaining the full transcript within 24 hours, I reviewed 
it and contacted the participants for a follow-up interview based on their previous 
responses for accuracy of the data and to obtain clarifications and/or additional details in 
certain areas. The last interview was conducted on 8/27/17. 
While awaiting eight prospective participants, after additional investigation I 
found that most of my population sample is active in the online community where they 
find support from others fighting the same disease. After IRB approval for a change in 
procedure in early July 2017, I posted an advertisement for my research on various 
Facebook groups for long-term HIV survivors. The advertisement posted contained my e-
mail address for prospective participants to e-mail me with additional questions or to 
request the full consent that would enable them to make a better-informed decision. 
Twelve prospects initially submitted an e-mail requesting the consent form for review 
and eight e-mailed back their consent for possible inclusion. After one e-mail to the 
remaining prospects without a response back, I did not pursue them as participants. I 
reviewed the eight prospective participants’ forms to ensure they met the inclusion 
criteria; I later contacted them back to set up the initial interview. This lasted on average 





they would be contacted in a few days to schedule their follow-up interview, which lasted 
roughly 30 minutes.  
I did not encounter any unusual circumstances. However, during interviews there 
were instances where participants, while answering one question would unknowingly 
answer a question I was going to ask at some point later in the interview. I remained 
flexible and did not repeat a question already answered in this manner. Additionally, I did 
not redirect tangential responses, because I found what the participants were sharing was 
valuable. 
Data Analysis 
I used the same notebook throughout the interview process as a research log, 
writing down names and acronyms of the participants as well as interview dates. On the 
day of each interview, I wrote down the date, the start time, and overall length of the 
interview. At the end of each interview, I listened once more to the recorded audio then 
wrote down key elements and initial thoughts in the margin of the page addressed to the 
participant in question. Upon receiving back each transcribed document, I read it multiple 
times, noting similarities in experiences among participants as well as any other shared 
experiences not necessarily related to the research questions. When I encountered the 
need for added details or clarifications on a specific thought shared by the participants, I 
wrote them down and generated questions to be asked in the follow-up interview. 
After reading each transcript and adding key words and/or phrases pertaining to 





Nvivo style before importing the data into Nvivo software. I ran a query in Nvivo to 
confirm major experiences shared by the participants. Following that, I began the process 
of coding. Coding is a process used by researchers to purposefully section out specific 
segments of the interview transcript whether it be small segments of a sentence, a whole 
sentence, or a full paragraph when deemed to be relevant enough to answer the interview 
questions, but more importantly the research questions (Wong, 2008). While coding, I 
gradually and carefully organized each coded section under a specific category based on 
similarities. I read each coded category to ensure the containing segments were 
addressing the same idea and the responses were similar. The names that I chose for each 
category derived from the overall description of the participants’ shared ideas or 
language. Once I completed naming all the various categories, I grouped them under a 
broader group called themes to encompass the main idea at hand.  
Three main themes emerged from my analysis: ‘from fear of the unknown to 
ownership,’ ‘from ownership to survival,’ and ‘the constant struggle of surviving with 
HIV.’  
Theme 1: From Fear of the Unknown to Ownership  
The first theme encompasses three categories and emerged from interview 
questions one, two, and four. This theme describes that participants went from a state of 
fear to a state of ownership. 
Category 1: Fear, anger, and rejection. In this category, participants described 





“surprised,” “at a loss,” and “denial.” The majority of participants reported experiencing 
fear at the onset of the diagnosis because little was known about the disease process and 
its treatment. For instance, P1 stated “in the beginning it was very alarming because there 
was so much fear and ignorance and no knowledge about it.” P3 also stated, “the first one 
with the initial stage when I was diagnosed, it was—I was scared. I was shocked.” P2 
added, “I’ve been positive since the onset of the disease and at the time nobody was 
aware of HIV, you know, back then it was called HTLB3. Then they finally identified the 
virus and a couple years after that, they introduced AZT as the only drug.” P3 shared that 
he experienced tremendous fear surrounding his fate stating,  
I was scared. Didn’t know what to expect. Gave myself about five years to live, 
basically. A few of my friends around me died between two and five years, so it 
was a terrible time like watching a dragon move through my friends. And so, in 
1996 I thought five years. That’s it.  
While some, like P5 experienced anger “at first, I was extraordinarily angry, then 
I got it,” others experienced stages of denial as seen with P4:  
I was using methamphetamine to self-medicate, and go in too crazy, and just self-
destruct. I hadn’t really reached the point where I was ready to fight and do 
everything I could to baffle the virus. The fear was causing me to want to self-
medicate, and then dealing with the depression. So, I stopped counting suicide 





Category 2: Fear of rejection before acceptance. In this category, most 
participants reported waiting as long as possible before sharing their diagnosis with 
family members and/or friends for various reasons. P3 stated,  
I was scared to disclose my status to my colleagues, even my family, and 
eventually it became quite nice when I could do my part by telling. So, I went 
from actual fear to acceptance. But first my family was devastated and also 
scared.  
Others feared stigma or adding stress to their relationships. To that effect P7 reported,  
I just didn’t want to discuss it with anybody, and because of the judgmental, that 
people would think worse of you because of it, or just the psychological thing that 
after they find out, it could be traumatic or destroy something.  
P8 stated, “I did not disclose my HIV status to the rest of my family until I was 
hospitalized with PCP. Partly out of apprehension and anticipation of the stigma and the 
strain it would put on those relationships.”  
Some participants chose to openly share their diagnosis with friends yet ended up 
losing them. P8 stated, “I lost some friends in the 90s because I was open about my 
status.” P3 reported, “I feel like it’s messed up. I had a partner at the time and he sort of 
pushed me aside when I was diagnosed.” Other participants shared that they were already 
living with an almost nonexistent relationship with family members because of their 
sexual orientation. For example, P4 reported, “my brothers are both homophobic. Support 





my biological family found out I was gay, oh gosh 1977 when I was kicked out of 
the Navy for being gay. And I didn’t speak to them for about 30-35 years or so. 
And then once my father found out that I had HIV he started feeling guilty and so 
we started having some communication, but we never restored a normal healthy 
family relationship. My sister and brother still want nothing to do with me at this 
time. 
Despite the fear, a couple of participants were eager to share with their friends and/or 
loved ones for support did get that support. P9 stated, “I knew it was something I’d have 
to live with, and I dealt with it pretty well just that way, by telling one or two others that 
were already infected people and just telling them helped.” P10 added, “My family’s 
been pretty amazing I would have to say” and P6 stated,  
I was just uncomfortable with it, of course. I told my family. That went very well. 
It was hardest for my brother, of course, because he is having a hard time with 
just my being gay and then you throw this on top of it. I must say he has come a 
long way.  
Category 3: Ownership and self-advocacy. In this category, participants moved 
from a state of ownership to one of self-advocacy. P3 reported, “when I realized that it 
wasn’t going to happen, I wasn’t going to die, I started living again. And since then I 
have made the most of it. And now I’m planning to retire. I’m not planning for death.” P2 
noted, “HIV in my experience, this is a disease that every single patient needs to be their 





Early on I didn’t have a good relationship with my healthcare providers because I 
wouldn’t take the AZT so the doctor didn’t think I was cooperating with them. 
But I had side effects. I had neuropathy within two to three weeks of taking the 
pill. It was pretty intense and I just decided not to take it.  
Similarly, P6 reported, “I wanted to go as long as possible without going on medication, 
because the only drug, AZT had a lot of side effects.” P5 also rejected AZT because as 
she stated,  
I knew that AZT was killing people. That people who took AZT were dying. I 
mistrusted the meds. I knew I didn’t want to get on AZT. I knew I had to find 
support. I had to find a doctor who would trust me.  
Participants continued to self-advocate for their overall health. For instance, while 
seeking physicians to embark on this journey with her, P5 shared, “I was going to 
interview doctors, I made up a list of questions. I found one, I liked him.”  
Participants also shared their struggle to get on the medication or tolerating it. P3 
stated, “at first, the medication was incredibly expensive, I couldn’t afford that, and my 
grandmother paid for my medication for five years until our Medical Aid picked it up; 
because in 1996, it wasn’t covered by any Medical Aid.” P8 stated,  
I didn’t have insurance at the time and I was probably in the hospital more than 
out, with a list of—a lot. I was increasingly ill over the next several years. It was 
extremely difficult, then I was basically granted emergency Medicaid because of 





Those who were insured had to sometimes battle with their insurer for treatment. P2 
shared, “It took two years for the VA to authorize my surgery. And so, because it took 
two years my left leg is paralyzed because of it.” Along the same line, P8 shared,  
it has gotten more difficult to get sculptural treatment as of a couple of years ago. 
At one point, you could get the facial filler material through the program on a 
sliding scale based on income. Now, the reimbursement rate is so low that there 
are no doctors who will accept Medicare for that. So, it’s effectively not available. 
Also, if you have any insurance, they won’t give you the material. You have to try 
to battle it out with your insurance company. 
Some participants like P10 shared their struggle with tolerating treatment: “At first it 
wasn’t too bad. Then, I couldn’t handle any of the HIV meds, so between 2004 and 2008 
I was hospitalized probably about 25 times, so the last 12 years have been pretty 
miserable.”  
Participants noted that obtaining good coverage depends on the insurance. To that 
effect P2 stated,  
Because I am a veteran of the United States Navy, by and large my healthcare has 
been pretty good, I have access to great specialists at the VA. Now, I am aware of 
friends that have had issues with getting consults to specialty physicians because 
of their being on Medicare or Medicaid or you know whatever. 






Theme 2: From Ownership to Survival 
The second theme encompasses three categories and emerged from interview 
questions five to ten. In this theme, participants described moving from a state of 
ownership to a state of survival.  
Category 1: Knowledge and utilization of resources for survival. In this 
category, participants stated that from the moment they accepted the diagnosis, they 
started learning about the virus and P6 stated, “it was learning a lot about medications 
and pharmaceutical terminology, and things that you never thought you would become so 
aware of and so overwhelmed with.” Several mentioned that upon their diagnosis they 
were immediately linked to a local HIV clinic or provided information on various 
resources. P4 stated, “I just immediately got plugged into the AIDS service organization 
here. They hooked me up with everything.” P6 stated, “When I moved, I did my 
homework. I did my research. I found out where to go and what to expect” and P9 stated, 
“You’d have to ask a few questions, and a doctor or the county would direct you right to 
it.” Nonetheless, the majority of participants reported that the presence of these resources 
has been beneficial for them to not only acquire knowledge about the disease process and 
how to live as healthy as possible with it, but also to have social support. P10 reported, 
“They do a lot of tea time, they’ll have workshops on living well with HIV, how to make 
out your will, how to live on a budget, healthier exercise, healthy eating. So that’s really 





I have gone to HIV 101 classes; I have attended HIV University through WORLD 
the Women’s Organize agency. We have luncheon learns and dinners that are 
sponsored by the drug companies. We have a weekly social support group and 
activities. 
Some like P9 added, “The group therapy once a month helps.” 
While on their learning journey to survival, some participants reported that they 
began learning to be an example for others also facing the virus and going through stages 
they had already gone through. P1 stated, “I trained to be an HIV tester and counselor. I 
have done public speaking, I attend support groups, and I do peer navigation for newly 
diagnosed people.” P5 shared,  
I found a group of women here. We formed a support organization for women 
that still exists. The original group of us women really helped me get through 
those early years. I wound up doing AIDS work myself. I was an AIDS case 
manager for 18 years.  
P8 stated,  
I specifically work with a lot of the newly diagnosed people to insure they are 
immediately linked to care. And I generally mentor them for – anywhere for six 
months to a year to try to ensure that they remain in care for that first year. I do 
often see a direct impact, and being an example of just saying I'm here 30 years 
later, and I wasn’t supposed to live five years.  





I would go to the support groups. What I got a kick out of was going and talking 
with newcomers that were scared to death. I loved talking to them and letting 
them see, here is a long-term survivor. You can survive. It is not a death sentence 
anymore. You don't worry. Basically, just sort of be with them and support them.  
Lastly, P2 noted, “While I was working I became an HIV/Aids certified RN.” 
Category 2: Societal support, another key to survival. In this category, 
participants outlined the importance of societal support to their survival whether it is 
from immediate family or partners, society via support programs, or friends. Some 
participants reported the benefit of utilizing the available resources to avoid more solitude 
and depression. P6 stated, “And yeah, the activities – the more the better. It’s kind of cool 
that they're pretty active like this. I need to do this because I get depressed so easily. I 
gotta keep busy.” Others like P1 added,  
I wish there were more social things you know. Sometimes it gets old talking 
about HIV all the time. I attend a support group even though sometimes they 
repeat the same presentations over and over. I go for the emotional support and 
the socialization.  
More than half of the participants reported having familial support either from 
immediate family or from their partner. For example P1 stated, “now we have an 





All were very much supportive, they all came to visit me in the hospital numerous 
times, because I was in the hospital numerous times. They provided some 
financial support, although none of them was in the – a great position to do that.  
P10 shared, “When I do get sick, one of my siblings will come out and help me, or a 
cousin will come out and help me. And that’s happened more often than I care to.” P5 
stated, “My main support is through my partner; which is not the best scenario. If 
anything happened to him, I would probably be devastated;” and P2 stated, “My sister 
and brother still want nothing to do with me at this time. So my husband is my family, 
and I’m his.”  
Some also shared this lack of familial support. P10 stated, “I’m not close with my 
family. My friends, you know, we really had to stick together. And most of them are dead 
now. It’s hard to make new friends.” P2 similarly stated,  
I’ve gotten to the point where I’m so independent without them that as this point 
in my life they don’t have any effect on me. Now, when I was very sick you know 
it would have been very nice to have some familial support particularly after the 
time I left my ex because I had marginal income, but I didn’t have that family of 
support to fall back on. So, I just had to make do with the best I could.  
Others shared issues that arose in their workplace over the years because of their 
status. P1 stated,  
I had been a waitress prior to having HIV and I was told when I got out of prison 





which turned out to be false. But because I believed the parole board I gave up 
over ten years in the culinary union. I gave up a pension and was forced to work 
other places.  
And P10 stated,  
I was fired from a job for being positive. Unfortunately I told a coworker about it, 
and that day I was fired. They told me I was fired for stealing, and I don’t steal. 
So I believe that’s why I was fired.  
Category 3: Effective patient-clinician partnership. This category outlines the 
importance of a good relationship between the participant and his/her HIV clinician. For 
the most part, participants reported having a good partnership with their clinician. They 
all described the latter as more often than not a regular general practitioner, and in some 
instances a general infectious disease specialist in lieu of a specialized HIV specialist. P2 
stated,  
I go to the infectious disease clinic. In the VA system they have no HIV 
specialists and they don’t treat a tremendous number of HIV positive patients. So, 
sometimes I end up being the teacher to providers, even occasionally to the 
infectious disease docs that I’ve had over the years.  
Others also reported seeing generalists who seek beyond their scope of practice for their 
patients. P4 stated, “He is not a specialist, he is a regular family physician but in his own 
right because of the attention he pays and the talks he does on HIV and AIDS, he is 





physician. P8 stated, “I go to a life based clinic at the medical university, which is an ID 
specific clinic” and P1 added, “I go to the Wellness Center, which is the primary HIV 
care.” Despite the type of physicians that they see, they all reported having sort of a 
partnership with their doctor, which helped in their journey to survival. P5 stated, “I had 
to find a doctor who would trust me. I found a doctor that would listen to me. That I 
trusted and would watch my T-cells with me;” and P8 stated, “my relationship with my 
doctor is great. He and I actually hit on some of the things committees offer, so we 
genuinely have a great partnership.”  
Theme 3: The Constant Struggle of Surviving with HIV 
This theme emerged from interview questions twelve to twenty. In this theme, 
participants shared their constant struggle of living with the virus as well as living with 
the side effects and comorbidities that developed overtime.  
Category 1: Daily survivorship. In this category, participants shared their daily 
survivorship. They reported that although some days might be decent, most are not. P7 
stated, “I’ll go a week where I just completely forget, on top of the world. And the next 
week, suddenly I can’t get out of bed, and then it causes me to get depressed.” P2 added, 
“It’s just that some days you have really good days and some days you have days that are 
– you feel like you have been run over by a Mack truck.” Participants shared the 
frustration and struggle with their newly day-to-day routine. In fact, P6 stated,  
The medication is almost a part time job for me. I am on so many medications 





I'm taking, of course, other medications for my back and my depression and for 
my heart. And so, it's pretty intense, and it is easy to miss when you take this 
many.  
P8 stated,  
I take five pills twice a day just for anti-virals. So, you know I’d say my biggest 
problem at this point is pill fatigue. I don’t allow myself to give into it but I go 
through periods when I resent every pill I do have to take.  
The majority of participants shared that they have come a long way from having 
to take several pills a day or a bigger dosage to smaller amounts. In fact, P7 stated,  
I was on sometimes upwards of 25, 30 pills a day, and had to take them in the 
morning and the afternoon, and your whole existence revolved around when you 
needed to take your medication, when you needed to eat something, or these are 
on an empty stomach, and whether you need to do all these things.  
P8 stated, “It is fewer pills – I mean I still take five pills twice a day just for antivirals but 
that is a far cry from 30 pills a day, that was just antivirals at one point.” P1 stated, 
“Today I take one pill once a day for HIV where as little as ten years ago I was taking 
forty to sixty pills a day.” P2 pointed that the dosage was way too high: “I was taking 
2400 mg of AZT a day. The dose of AZT now is about 200 mg a day. But that was the 
only drug they had to give us and it just made me sick.” However, some shared the 





I take about 36 pills a day. So I really have to keep on top of the pills. It just really 
sucks. I have friends that have been on therapies for 10 years and I’m lucky if I 
can get a year or two. 
Participants reported a series of noted side effects, which add to their daily 
struggle. These side effects are either from the medication used to treat the virus and/or 
for having lived with the virus for such a long period of time. For instance P1 reported, 
“insomnia, chronic diarrhea, and the gastrointestinal.” P2 stated, “extremely vivid dreams 
and chronic diarrhea.” He added, “I don’t attribute the diarrhea to the medication, I 
attribute it directly to the HIV itself.” P6 reported, “It was a combination of the diarrhea 
and the nauseousness and perhaps it gave me a little bit of an uneasiness.” Other 
recurring side effects mentioned by most participants were “osteopenia, osteoporosis, 
pericarditis, back and bone pain, extreme fatigue, mental issues, dyspareunia, decreased 
libido, chronic kidney disease, lipo dystrophy, lipo atrophy, peripheral neuropathy, 
memory loss, memory loss, poor concentration.” 
Category 2: Aging before your time. In this category, participants reported 
noticing that they are aging before their time. This could be due either from the disease 
process itself, from being on the earlier ART drugs, and/or simply from the side effects of 
the current drugs. Most participants reported extreme fatigue, which they are 
experiencing more often and which prevents them from being as active as they once 





So you got two things going after your body, side effects, as well as the HIV 
virus. You lose a lot of your energy and a lot of your stamina, endurance. I am 
slowed down because of my back, and that pisses me off.  
P3 added, “I am more fatigued now. I get tired more easily. I used to go jogging on the 
beach with the dog. I can’t do that anymore, that’s my main frustration.” P8 stated,  
The fatigue is probably in a lot of ways my biggest challenge at this point 
especially returning to work full time. I do not have the stamina that I would 
expect to have as a 61-year-old man. Sometimes at my lunch hour I close the 
office door and take a nap for an hour, and then there have been a few days when 
I simply called in because I just could not make it through a day in the office.  
P10 also stated,  
There’s a lot of fatigue, so there’s a lot of worry about the side effects with the 
bone density, the liver. Every pill I take has a side effect, so we can’t really tell 
what is really causing all the fatigue.  
Others also experienced neuropathy, which made it difficult for them to get around. In 
fact, P3 stated, “I try not to talk about it all the time, the side effects, especially the 
neuropathy. I get frustrated with myself. It’s fairly uncomfortable to walk around – I try 
and maybe hide it.” P10 added, “I have neuropathy from the waist down, so it’s hard to 
get around.”  
Some participants pointed out memory loss as an issue too early to happen at this 





I am having issues with memory and concentration. I just feel like I'm 
inappropriate to my age. I will often struggle for a word that seems to me that’s 
something that people significantly older than me do as often as I do.  
Similarly, P10 reported, “I am now experiencing memory loss.” 
Other participants stressed going on disability not by choice but again as a result 
of either the virus itself and/or the side effects from the medications. To that effect, P2 
stated,  
Because of HIV I have lost the ability to work not once, but twice, the first time 
being in ’99 and the second time being in 2013. And the first time was a direct 
causation from the HIV. The second time was from the side effects of at least one 
of the medications, we don’t know which medication.  
P6 stated,  
I was forced into retirement through disability. And I wasn't prepared for 
retirement at all. I wasn't ready to retire, but I was unable to work through 
disabilities. HIV does affect your entire body and it makes it weaker.  
P10 added,  
Between 2004 and 2008 I was hospitalized probably about 25 times. So, I have 
had pericarditis as a result of one of the meds. I had to go on disability, which I 
wasn’t too happy about. And then I asked my doctor when I was gonna go off 





Category 3: Existing despite the odds. In this category, most participants 
described their current quality of life as not really “living” more like “existing”, fighting 
one battle after the next. In fact, P7 stated, “I am existing. It’s very difficult to find joy in 
things. You try to distract yourself with projects and volunteerism and things like that.” 
P8 shared, “I went on disability in ’94 and I basically lived poverty from the time I went 
on disability.”  
Participants also shared aspects affecting their lives. In fact, the decrease or lack 
of libido among several has impacted them. P7 stated,  
My sex drive has been affected. I definitely have nothing for ten years. I feel like 
less of a person. It is like that was part of my joy. It is like breathing and eating. 
Now, I have no sex drive. I try and take pills. I try and take steroids. I try 
whatever to try and get my libido. It has just ruined that for us.  
P8 added,  
Basically I have no sex life at this point, I have very low libido for like 5 years, 
which seems to me to not be appropriate for someone my age. I am very self-
conscious about my appearance, especially without any clothes on. And my 
libido, it’s not because my testosterone is low, because I have had that monitored. 
Who knows how much that might be due to HIV itself, to the stew of chemicals I 
take every day, I don’t know but it’s inappropriate for my age.  






I can't have normal sex now, because I have too much pain. It's painful to have a 
penis in my opinion. I don't think that other menopausal women who don't have 
HIV have that necessarily, I don't know. 
The majority of participants similarly reported struggle with change in 
appearance, which affects their self-esteem. In fact, P7 stated,  
Fat distribution – one of the side effects is that you have light atrophy where the 
muscle patch in your face disappear, and so suddenly you're walking around 
looking like a human skeleton. You look in the mirror and – and I don’t think 
anyone’s really fond of looking in the mirror at all, just even to comb your hair, 
brush your teeth. It’s like a passing glance because it just makes you too 
depressed to see the physicality’s that’s happened.  
P6 added,  
The loss of muscle – I probably got to see that about five years in when I started 
the medication, and I also have the flaps on my face from the muscle loss. My 
arms and legs are quite thin for a big guy, and my legs, my veins are very 
pronounced. This all started about five years in. So you’re looking at about 1995.  
P3 also stated, “redistribution of body mass. I found my stomach is quite a bit bigger. 
I’ve lost mass on my legs, my arms and my bum.”   
P8 added, “My body shape changes, the fact that my ass, quite frankly, is deflated. It 





Several participants shared another aspect affecting their appearance and thus 
self-esteem: lack of dental coverage. In fact, P8 stated,  
Medicare still does not offer preventive dental coverage, except for emergency 
extractions, and even that’s very limited. So at this point, after years of just not 
having access to anything, I had a bunch of teeth that rotted out and have now had 
to be extracted.  
And P7 stated,  
In treating people with HIV, we have to find a way to help people keep their teeth, 
and to keep their smile, and to not show the signs on your face. Because it's like if 
I'm walking down the street, most people don't think that's a gay guy. But, 
because of were the teeth were, and my face- the lipo atrophy, I look sick. People 
would go, "He must be…," Do you know what I mean? But, there should be some 
level of preventative dentistry. Because you can't go through life--you're just 
already defeated before you even step out the door if you don't have a smile, if 
you don't have the teeth.  
Evidence of Trustworthiness 
To ensure credibility of the study and thus genuine participation and shared 
experiences, I reminded each prospective participant that, as stated in the consent, they 
had the right to decline participating or withdraw at any given time without any 
explanation. At the beginning of the interview and throughout the process of the study, I 





were as comfortable as possible. This enabled them to openly share in depth information 
regarding their experience with the phenomenon at hand. Throughout the interview 
process, member checks were performed. Specifically, at the end of the initial interview 
and after review, a follow-up interview was conducted to obtain clarification where 
needed as well as perform member checks to assess the accuracy of the collected data. 
To ensure transferability in my study, I reported information on the phenomenon 
at hand as well the overall descriptive details on the research findings. This will enable 
other scientists to ensure transferability in their own research and thus decide whether 
those findings are credible enough (Shenton, 2004). Additionally, I provided details 
pertaining to the participants’ demographic characteristics and specific parameters 
pertaining to how the study was conducted, so it could be easily replicated if needed.  
Dependability in this study was maintained by providing the reader with a 
detailed methodology used in my study, ensuring that a similar study done in the same 
context, using a similar method, and with the similar type of participants would be easily 
replicable by other scientists (Shenton, 2004). Additionally, I ensured to keep a trail of all 
documentation pertaining to the research (Creswell, 2009). Specifically, I kept all audio 
and transcribed transcripts, as well as journal notes so that other scientists could easily 
retrace and replicate if needed. Confirmability in this study was maintained by showing 
the reader that presented results derived in fact from collected data and not from my own 
interpretations (Shenton, 2004). As such, I provided direct quotes from the participants 






Throughout my research, I sought to answer three main research questions labeled 
RQ1, RQ2, and RQ3. Based on the conducted analysis, three themes were substantiated 
from various interview questions to answer the above research questions. Theme 1, 2, and 
3 respectively answered RQ1, RQ2, and RQ3. 
RQ1: What are the experiences of people 50+ living with HIV? 
Theme 1: From fear of the unknown to ownership  
Participants shared that their 20 to 30 years of experience from the time they 
received their diagnosis until today has been met with ups and downs. All of them went 
from a state of fear, anger, or denial of the then, unknown virus to the medical body, to a 
state of acceptance and thus ownership. P3 had stated, “with the initial stage when I was 
diagnosed, it was – I was scared.” As such, in their own way, they embarked in a quest of 
knowledge to be better self-advocates and ultimately live a life as healthy and as long as 
possible with the treatments available to them at the time. However, the journey would 
not be without challenges. In fact, just as they had overcome fear of the virus and death 
that comes with it, they had to overcome fear of possibly being rejected by their loved 
ones and/or friends whom they would need for support and strength. To that effect, P7 
reported,  
I just didn’t want to discuss it with anybody, and because of the judgmental, that 
people would think worse of you because of it, or just the psychological thing that 





Additionally, they had to overcome the challenge of attempting to acquire the pricey HIV 
medication when uninsured or unemployed as well as tolerating and surviving the effects 
of the only medication available for those that were able to acquire them. P8 shared, “I 
didn’t have insurance at the time and I was probably in the hospital more than out, then I 
was basically granted emergency Medicaid.” P10 on the other hand shared, “I stopped 
taking the AZT because I had neuropathy within two to three weeks of taking the pill.” 
RQ2: How do people 50+ describe their experiences with HIV? 
Theme 2: From ownership to survival 
Once they passed the fear and denial stage, all participants had the desire to tackle 
the virus head on, one challenge at the time to survive as long as possible. As such, they 
dove deeper into self-educating on the virus, this time using various available HIV 
resources and programs.  
P1 shared, “I have gone to HIV 101 classes and attended HIV University.” In the 
midst of all their numerous and frequent stays in the hospital, several participants pointed 
out the importance of having some kind of societal support whether from immediate 
family or partners, friends, or via social groups. P2 shared,  
When I was very sick it would have been very nice to have some familial support 
particularly after the time I left my ex because I had marginal income, but I didn’t 
have that family of support to fall back on. So, I just had to make due with the 





Additionally, they shared tremendous stigma and injustice in the workplace in those 
times. For example, P10 stated, “I was fired from a job for being positive.”  
Lastly, maintaining a healthy partnership with one’s clinician was also addressed 
as important. Participants shared that regardless of the fact that their clinicians are mostly 
non-HIV specialized physicians, they are specialists in their own right and more 
importantly, they listen to them and are open to learning from them. In fact, P2 shared, 
“sometimes I end up being the teacher if you will, to providers” and P5 added, “I had to 
find a doctor who would trust me. I found a doctor that would listen to me.” 
RQ3: How do HIV-positive patients older than 50 describe the challenge of living with 
HIV and diagnosed comorbidities?  
Theme 3: The constant struggle of surviving with HIV 
Participants shared that their journey has not been without any challenges; in fact, 
it has been filled with side effects. The latter emerged from various HIV medications as 
well as from the long-term inflammatory process of HIV within their body. For example, 
P10 shared, “There’s a lot of fatigue. Every pill I take has a side effect, so we can’t really 
tell what is really causing all the fatigue.” They also shared constant struggle of keeping 
up with daily intake of their numerous pills to resenting them at times. P8 stated, “I take 
five pills twice a day just for anti-virals. So, you know I’d say my biggest problem at this 
point is pill fatigue, but sometimes I resent every pill I take.” Additionally, they shared 
that as years went on, some side effects became chronic affecting their daily lives. To that 





Because of HIV I have lost the ability to work not once, but twice. And the first 
time was a direct causation from the HIV. The second time was from the side 
effects of at least one of the medications, we don’t know which medication.  
Other side effects affected not only their physicality but also their self-esteem, aging 
them before their time. P7 stated, “Fat distribution – one of the side effects is that you 
have light atrophy where the muscle patch in your face disappear, and so suddenly you're 
walking around looking like a human skeleton.” However, the combination of multiple 
side effects coupled with numerous hospital stays forced the majority of participants into 
disability several times. Overall, they have come a long way; they are indeed survivors as 
P4 reported, “Frankly, I feel as though I have walked through the valley of the shadow of 
death. I done come out the other end. You know what I mean?” 
Summary 
The purpose of this phenomenological qualitative study was to assess the 
experiences of people 50+ and older living with HIV. Ten participants took part in the 
study, undergoing open-ended recorded interviews following a pre-made questionnaire. 
Once transcribed, the data was analyzed using Nvivo 11 software where the coding 
process enabled categories and later themes to emerge. The following themes emerged 
from the analysis: ‘from fear of the unknown to ownership,’ ‘from ownership to 
survival,’ and ‘the constant struggle of surviving with HIV.’ 
These three themes enabled me to answer the three research questions that drove 





horrible in the earlier stages due to all the fear surrounding the lack of knowledge, the 
experience with the earlier drug, as well as the fear of immediate death as they witnessed 
several of their friends quickly succumb to the infection. They described their lived 
experiences as a daily survivorship between self-education, self-advocacy, and various 
challenges that develop overtime. Finally, they described their challenges of living with 
HIV and the comorbidities that develop as a constant struggle. In fact, besides having to 
stay on top of their medication, they also have to adjust day by day to the series of side 
effects that develop. Moreover, some had to adjust to being forced into disability before 
their time because of their non-properly responding body, a body supposedly young 
enough to carry them yet too weakened by the virus and/or the medication treating it. The 
lives of these survivors today are described as merely existing; existing in a world where 
they have lost their appearance overtime, their self-esteem, and now slowly losing their 
memory yet, still fighting for better days ahead. 
In the next chapter, I will concisely summarize the findings before sharing the 
interpretations of the results, discussing the limitations of the study, recommendations for 







Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this qualitative phenomenological study was to explore the lived 
experiences of participants 50 years old or older living with HIV and comorbidities to 
gain an understanding of the challenges they face, providing information that can 
improve their quality of life. After review and analysis of the collected data, three themes 
emerged: ‘from fear of the unknown to ownership,’ ‘from ownership to survival,’ and 
‘the constant struggle of surviving with HIV.’ These themes were used to respectively 
answer the three research questions that drove my study. Overall, most participants 
described their 20 to 30-year experience as fearful in the early onset of the diagnosis 
followed by a period of acceptance, self-education, and self-advocacy to overcome the 
challenges that came to light overtime. Despite the constant struggles they face, 
participants described their journey as that of daily survivorship. To that effect, P3 stated, 
“I’m surprised every day. Every morning my first prayer is thank you God for another 
day. Every day. So, it’s just wonderful.” In the following chapter, I will address the key 
findings of the study, the interpretation of those findings, the limitations of the study, 
recommendations, implications for social change, as well as an overall conclusion. 
Interpretation of the Findings 
What are the Experiences of People Living with the Virus? 
Participants shared their experiences of living with the virus as one filled with ups 
and downs and with higher incidence of side effects in form of comorbidities. These 





HIV is prone to comorbidities. Additionally, some participants shared their frustration in 
attempting to acquire ART after their initial anger or denial phase as well as the battle 
between their body and the medication; however, they had a strong will to follow through 
with the treatment to live as long and as healthy as possible. To that effect, depending on 
participants’ respective years of diagnosis, they reported surviving 20 to 30 years with a 
virus they were originally speculated to succumb to in at most 5 years if that. This 
confirms the findings of Samji et al. (2013) that if diagnosed and placed on ART early 
on, HIV patients are expected to live up to 70 years old.  
How do People 50+ Describe their Experiences with HIV? 
Participants described their experiences as multifaceted from diving into self-
educating, to struggling with fear of rejection from societal support, to isolation, and to 
developing somewhat of a partnership with their respective clinicians. In accepting their 
diagnosis, some participants decided to share that diagnosis with their societal “support” 
despite fearing rejection. This societal support varied from immediate family or partner, 
to friends/co-workers, to society via support groups. Unfortunately, some reported 
experiencing episodes of depression as well as stigma early after being diagnosed. This 
confirms the findings of Brennan et al. (2011) that this population may be affected by 
depression. Some of my participants reported experiencing solitude which led to 
depression due to moving into a newer community in which they were no longer 
surrounded by their peers. They lacked the support they needed from individuals sharing 





lonely, you know, one thing that would really have to change would be to have more gay 
people around or to make it easier to meet people, because I think that diminishes the 
quality of life.” This confirms the findings of Sankar et al. (2011) that while 25% of baby 
boomer HIV patients were moderately depressed due to overall poor physical health and 
lack of social support; 39% could be diagnosed with major depressive symptoms due to 
isolation (Sankar et al., 2011).  
Additionally, some participants emphasized that they tend to be more isolated as 
they age for various reasons, confirming the findings of Liu et al. (2014) that social 
interactions among older HIV patients were lower than their counterparts. Some reported 
isolation as a self-choice because most to all of their friends succumbed to HIV infection. 
To that effect, P8 stated, “in many ways my original circle of friends as an adult are 
probably three-quarters gone.” Others are simply choosing solitude rather than 
experiencing rejection for being positive and not initially disclosing it or for simply being 
positive. To that effect P4 stated,  
it is isolating. HIV tends to isolate people. Not always, but it can. You just want to 
be with yourself. Because like if you meet somebody nice, you didn’t tell them 
you were HIV positive from the get go, there is going to be a problem. But there 
is a problem. The problem is if you tell somebody you’re HIV, they don’t want 
anything to do with you. You are damned if you do. You’re damned if you don’t. 





Despite feeling isolated, most participants reported a good relationship as 
partnership with their HIV clinician; however, these clinicians were mostly regular 
clinicians or infectious disease clinicians as opposed to specialized HIV clinicians. As P2 
stated,  
the doctors and it even sometimes applies to infectious disease docs, they don’t 
treat a tremendous number of HIV positive patients. So, they may not have a 
tremendous understanding of the processes by which the body reacts to your long-
term HIV infection 
To that effect, P10 added,  
there’s a lot of worry about the side effects. Every pill I take has a side effect. I 
have to be very careful. I can’t take calcium with one of the HIV meds. I can’t 
take steroids with one of the HIV meds. I don’t think the hospital doctors knew 
enough, because they put me on steroids, and they weren’t supposed to put me on 
steroids. So, I’m suffering severe side effects the last two months with that. And I 
also have to educate some of the doctors in the ERs or in the hospital and say no 
to certain medications. 
This confirms the findings of Patel et al. (2016) that non-HIV specialists may not be as 
familiar with side effects and cross interactions of specific HIV medication with 
medication used to treat chronic diseases or side effects. This suggests that patients being 
initially treated and followed by HIV specialists are more likely to have a better 





are important to meet the need of the growing HIV population (Patel et al., 2016). Patel et 
al. also addressed a high incidence of HIV-infected patients with multiple untreated 
comorbidities, which they attributed to the use of clinics not equipped with properly 
trained HIV personnel. To that effect P2 stated, “the doctors don’t treat a tremendous 
number of HIV positive patients. So, sometimes I end up being the teacher if you will, to 
providers.”  
Moreover, Cahil and Valadez (2013) shared that there is a major lack of proper 
system to care for infected HIV patients 50 years old or older . Some participants reported 
lack of proper care such as with the side effects they develop or the battle with their 
respective insurers for various medications and/or procedures. To that effect, P8 stated,  
even having Medicare D and Medicaid in addition to that, having to appeal so 
many things that my Medicare D carrier has said, well, you can’t have that is a 
struggle. And having to go through an appeal process repeatedly to actually get 
medication that was appropriate to me is difficult. I was having muscle cramps. I 
still have a problem with that. And all of the medications that they kept insisting, 
no, take this instead, were directly counter indicated with my other medications. 
So that’s just a constant battle to keep the proper prescriptions flowing to the 
extent possible. 
Some findings contradicted research I found in the literature review. Mugavero et 
al. (2013) and Patel et al. (2016) suggested that half of baby boomers lack access to HIV 





having access to basic HIV care as well as good follow up and retention, despite the fact 
that their respective insurance carriers caused difficulty in seeing specialists to treat their 
comorbidities.  
How do People 50+ Describe the Challenges of Comorbidities? 
Participants described their experience of living with the virus and comorbidities 
as a constant struggle, making it difficult for them to get around and enjoy a normal life. 
This confirms the findings of Rueda et al. (2014) that for older HIV patients, the 
multimorbidity was coupled with decreased physical functioning. My analysis showed 
that the longer participants had lived with the virus and the longer they had been on at 
least one ART, the more they experienced a major impact on their physical body such as 
fatigue or lack of stamina, making it challenging for them to get around. Oursler et al. 
(2011) confirmed this in reporting a significant decline of physical function among HIV 
patients older than 55 years (p < 0.001) as opposed to their counterparts who were not 
infected. On the same note, Patel et al. (2016) showed that years living with the virus and 
use of ART were significant predictors of onset of comorbidities among older HIV 
patients.  
Participants reported that being on ART did prolong their life, however, it also 
increased their onset and incidence of comorbidities over the years. This is in line with 
findings of Vince et al. (2011) and Kim et al. (2012) that the longer this population lives 
with HIV, the longer their list of medications to treat their comorbidities. My analysis 





long-term usage of ART and living for a long time with the inflammatory process of 
HIV. Rueda et al. (2014) and Negin, Martiniuk et al. (2012) noted a higher onset of 
comorbidities and its number among this aging population on ART as opposed to those 
not on ART. Rueda et al added that at least 94% of HIV-infected older patients on ART 
presented with at least one comorbidity, with the majority presenting with at least three; 
which is consistent with findings among my participants. Negin, Martiniuk et al. and 
Deeks et al. (2013) also reported a similar increase. In other words, being on ART for an 
extended period of time is a major risk factor for early onset of chronic diseases as well 
as both multimorbidity and the challenges that come with it. 
Some of my findings contradicted the research in my literature review. Liu et al. 
(2014) reported that the older the HIV patient was, the lower the level of well-being, the 
higher the level of depression, and the poorer the quality of life; which they attributed to 
low physical health and ongoing psychological challenges (Liu et al., 2014). However, I 
found that although some participants reported experiencing the above at one point or 
another, it was more so due to the number of years living with the virus, hence the effect 
of both longer-term inflammatory process of the virus and usage of ART on their body as 
opposed to their being or getting older.  
Social Constructivism. Using this framework by Berger and Luekmann (1966) 
enabled me to understand the phenomenon at hand, notably, the lived experiences and 
daily challenges of people 50+ living with HIV from their own perspectives as they age 





specialized HIV providers despite getting good care from the self-proclaimed HIV 
clinicians. P2 stated,  
I go to the infectious disease clinic. In the VA system they have no HIV 
specialists and they don’t treat a tremendous number of HIV positive patients. So, 
they may not have a tremendous understanding of the processes by which the 
body reacts to your long-term HIV infection. So, sometimes I end up being the 
teacher to providers, even occasionally to the infectious disease docs that I’ve had 
over the years. Because I’ve got specialized education that they haven’t had, you 
know they were educated as generalized infectious disease docs, not HIV docs 
P4 stated,  
My doctor is really good. He trains doctors. Then, he has new doctors come in, 
they talk to me and I train them along with some of his other patients. Also, I have 
gone through so many HIV case managers. Some of them are wonderful. Some of 
them are idiots. Some of them don’t know what they're doing. Some of them 
shouldn’t be doing it. 
Additionally, other participants shared the shortage of gynecologists treating or 
specialized in HIV women care; hence, they face a in finding someone qualified enough 
to address their concerns of aging with HIV while going through menopause. To that 
regard, P5 stated, “None of the gynecologists know anything about women necessarily. 
That’s the thing the women talk about in some of our groups. We don’t know what is 





shows that despite their efforts at providing care for this population, providers still lack 
the necessary knowledge. It is important for providers to be knowledgeable on poly-
pharmacy and various interactions among such medications and the process by which the 
body reacts to long-term infection. This stresses the need for specialized HIV clinicians 
that could address the current and pressing concerns of this population.  
Another aspect participants pointed out was in regard to isolation. Some 
mentioned the need for more activities: “it is isolating. HIV, it tends to isolate people. 
Not always, but it can. You just want to be with yourself” (P4). P1 added,  
we tend to isolate more as we age . . .  I wish there were more social things like, 
you know, a lot of people, because they’re living on such a fixed income, can’t 
afford to go to like a show or even a movie. If they could take us to a movie or 
something, it would be nice. 
Finally, P10 stated, “It’s just easier to be by myself. I guess I have fallen into a routine 
the last few years of you know I have my dog and that’s all I need. You know I really, I 
guess it’s not easy making new friends.” 
Advocacy Worldview. Using this framework by Heron and Reason (1997) 
enabled me to understand and improve the health conditions of my participants. To do so, 
I listened to their shared experiences and more importantly their current needs, which 
could be used to contributing to policy changes and designing of appropriate programs. 
Brennen et al. (2011), Patel et al. (2016), and Cahil et al. (2013) reported the lack of 





knowledge surrounding their needs, stressing that such knowledge could improve their 
current quality of life. Participants raised some concerns and needs of today such as 
current needs for specialized HIV clinicians better equipped to grasp how their bodies 
react to the series of medication overtime or how their body ages on ART while tackling 
menopause for instance. They also shared needs for more activities to reduce the isolation 
that they face. 
Participants also shared their needs for policies that would enable them to obtain 
adequate medical coverage to treat the side effects of being on ART for so long and aging 
with the disease. For instance, they stressed the need for basic dental coverage, which 
affects their appearance and self-esteem. Some participants mentioned that such 
preventive coverage is not available:  
Medicare still does not offer preventive dental coverage, except for emergency 
extractions, and even that’s very limited. So, at this point, after years of just not 
having access to anything, I had a bunch of teeth that rotted out and have now had 
to be extracted. (P8)  
P7 stated,  
In treating people with HIV, we have to find a way to help people keep their teeth, 
and to keep their smile, and to not show the signs on your face. Because it’s like if 
I’m walking down the street, most people don't think that's a gay guy. But, 
because of were the teeth were, and my face- the lipo-atrophy, I look sick. People 





level of preventative dentistry. Because you can’t go through life—you’re just 
already defeated before you even step out the door if you don’t have a smile, if 
you don’t have the teeth.  
Additionally, participants stressed the need for access or coverage to sculptra treatments 
for lipo-dystrophy and lipo-atrophy. Participants like P8 shared,  
it has gotten more difficult to get sculptural treatment as of a couple of years ago. 
At one point, you could get the facial filler material through the program on a 
sliding scale based on income. Now, the reimbursement rate is so low that there 
are no doctors who will accept Medicare for that. So, it’s effectively not available. 
Also, if you have any insurance, they won’t give you the material. You have to try 
to battle it out with your insurance company. 
Limitations of the Study 
In my study, I included participants who were 50 years old or older, had lived 
with HIV for at least 20 years, were on at least one ART, and had at least one 
comorbidity to explore their experiences of living with HIV and the challenges that 
develop overtime. Since I used a phenomenological approach, one limitation is that my 
findings cannot be generalized to a population group that does not share the phenomenon 
in question (Shenton, 2004). Additionally, I used 10 participants in my study and because 
of this adequate yet small sample size, the overall study results might not be 
generalizable to a larger population even sharing the same phenomenon in question 





throughout the interview might not reflect that of the entire population living with the 
phenomenon even with similar backgrounds. The last limitation noted was the fact that 
only 20% of my participants were female, hence minority, as opposed to their male 
counterpart.  
Recommendations 
As stated in previous paragraphs, I used a phenomenological approach to explore 
the lived experiences of 20-30 year-old HIV survivors. Hence, the findings cannot be 
generalized to a larger population. Nonetheless, based on my findings, additional studies, 
noted below, could be conducted to uncover additional knowledge that could benefit this 
population.   
• A mixed study exploring the experiences of menopausal women aging with HIV 
and the challenges that develop, as well as the relationship between aging with the 
virus and early onset of menopause.  
• A qualitative study exploring the experiences of steroid use among long-term HIV 
patients on ART treatment.  
• A comparative study on the effect of steroid use on short-term HIV patient on 
ART treatment versus long-term HIV patients on ART treatment.  
• A comparative study assessing the relationship between long-term HIV infection 
and decreased sexual drive between male and female. 
• A qualitative study exploring the effects of long-term HIV infection on sexual 





• A quantitative study assessing the relationship between aging with HIV and early 
onset of isolation.  
• A quantitative study assessing the correlation between aging with HIV while on 
ART and early onset of disability.  
• A quantitative study assessing the correlation between HIV long-term survivors 
and early onset PTSD.  
• A quantitative study assessing the incidence of early onset of memory loss among 
HIV long-term survivors.  
• A mixed longitudinal study exploring the experiences of ART use among long-
term HIV survivors; and comparison/contrast of the side effects of similar ART 
dosages between males and females. 
• A comparative study assessing differences in long-term prognosis between long-
term HIV patients followed by HIV specialized clinicians versus non-specialized 
clinicians.  
Implications 
I recommend that positive social change in the lives of people 50 years and older 
living with HIV start with mutual trust and respect between this population and their 
health care associates, notably HIV clinicians, HIV nurses, and HIV case workers. 
Researchers who are the voice of these participants in providing their gathered 
information and stakeholders who could use the collected data to outline and implement 





was able to uncover and get a better understanding of the challenges HIV+ participants 
face, as well as their daily experiences of living with HIV and comorbidities that develop. 
Using the reported data, other scientists could frame additional research questions for 
further studies, to expand even more the current body of knowledge in order to improve 
the quality of life of this population. Additionally, the healthcare associates, first in line 
in hearing the challenges and needs of the patients, should work closely with stakeholders 
and insurers to develop policies that would improve for instance their appearance and 
thus self-esteem, by ensuring they at least obtain basic preventive dental coverage under 
their insurance, which would enable them to access services not solely limited to 
emergency extractions. Moreover, healthcare associates and stakeholders should work 
with manufacturers and insurance companies in developing a sliding scale that could 
enable them to afford sculptra treatment, both procedure and injection material, based on 
their income.  
Moreover, community programs ought to develop appropriate social activities to 
keep this population as occupied and active as possible as they tend to isolate more as 
they age as this could possibly lead to depression. To that effect, P1 stated,  
I think a lot of people that are considered long-term survivors like twenty-plus 
years maybe or even ten plus years feel that they are being put on the back burner, 
they start isolating themselves. I mean I attend a support group even though 
sometimes they repeat the same presentations over and over I go for the emotional 





Healthcare associates should then work with HIV programs and stakeholders in 
developing more activities for this aging HIV population already living on a fixed 
income, to get them out of solitude and thus depression. Similar to the Meals on wheels 
system used for our elderly population, HIV programs could develop and implement a 
sort of Friends on Wheels program for those who are too weak to leave their house. The 
latter could be beneficial for them just to have on a weekly basis someone to talk to, play 
a game of checkers, or even take a walk to the park with when they physically feel 
somewhat better.  
However, for those like P4 who stated,  
the older I get, the more I tend to dislike human beings. I tend to want to isolate 
and not be around people. That's something I really struggle, because people can 
be jerks. I socialize on social media. I need to socialize more to have a better 
balance.  
Or P10 who noted, “I guess I spend a lot of time in bed. The exhaustion is a key piece, so 
that causes a lot of isolation,” developing a sort of Friends on Line program might be a 
better way for them to socialize. Depending on the preference of the participant, this 
could vary from a simple weekly telephone call, to an internet video call, to an internet 
chat conversation for those still reluctant to the face-to-face aspect or still working 
towards it. I think it could be more impactful to once in a while have a team of 
volunteers, for either program, that are themselves HIV survivors or even newly 





challenges, the recipient might be more receptive to opening up to someone that may 
have a better understanding of what they are currently experiencing. Additionally, if the 
volunteer is newly diagnosed, the recipient might even find meaning in sharing his/her 
experience thus impacting someone else while forgetting his/her own struggle for a 
moment. On the other hand, other participants might simply prefer a Friend on Wheels or 
a Friend on Line that is not living with the virus because as P1 stated, “sometimes it gets 
old talking about HIV all the time.”  
The information gathered from participants will be shared with stakeholders, HIV 
programs, and clinicians so they can better address those needs to promote better care for 
this population. Negin, Mills et al. (2012) showed that the incidence of HIV infected 
baby boomers is expected to nearly double, from 9% to 17% by the year 2040 (Negin, 
Mills et al., 2012). Deeks et al. (2013) similarly outlined the above, estimating that the 
number of infected HIV long-term survivors would triple to 9 million by 2040 (Deeks et 
al., 2013). As such, there is a crucial need to closely follow the health span of this 
population to identify any potential complications that may arise to address them in a 
timely fashion. To better assist this population as they continue to age with the virus, 
necessary steps ought to be taken for healthcare associates to grasp a better understanding 
of their daily challenges and needs, and thus reduce that burden. It is essential that the 
front line, notably the healthcare associates develop trust and partnership with the patient 
so they could easily open up to them and share their true challenges and/or needs upon 





periodically and brainstorm on how to better serve that population as well as how to 
better advocate for them via stakeholders.  
Additionally, despite them aging with HIV, which seem to take precedence over 
their overall health, the team of healthcare associates ought to stress the utmost 
importance of yearly physical exams with their regular physician, thus encouraging that 
follow through so that for instance women do not skip out on their mammogram and men 
on their prostate exams. To that effect, P1 shared, “I very rarely—I mean, I should go for 
a PAP smear every couple of years, just you know, and I haven’t in a while. I recently 
just had my mammogram, which I hadn’t done in four years.”  
In regards to being cared for by non-specialized HIV clinicians, P2 stated,  
there’s not enough of us and docs generally speaking don’t have enough time to 
investigate—I mean you think about all of the patients that they have and they’re 
not HIV docs—even the infectious disease docs for that matter are not specialized 
or solely treating HIV, so even they don’t have enough time to read the 
research—often it’s reliant upon a pharmacist or somebody else in the peripheral 
healthcare to make suggestions, rather than the providers themselves. 
P5 added, “there is no gynecologist who sees an abundance of women with a HIV. There 
is no specialty gynecologists for women. None of the gynecologists know anything about 
women, menopause, and HIV necessarily.” Lastly, P10 stated, “I have to educate some of 
the doctors in the ERs or in the hospital.” Based of the above it is clear that participants 





should work with HIV programs and stakeholders in framing policies and providing 
funding so that, clinicians interested in caring for HIV patients, may acquire additional 
specialized HIV education, attend infectious disease Continued Medical Education 
(CME) conferences on current HIV topics; but also, take the time to follow the research 
and seek understanding of the side effects and interactions between various ART used to 
treat them.  
Being that HIV clearly affects both males and females, pharmacists, emergency 
room clinicians or at least infectious disease clinicians seeing HIV patients in the 
emergency room settings, and gynecologists ought to also get current specialized HIV 
education if interested in treating that population. Moreover, guidelines could be 
developed to prevent clinicians not treating a designated amount of HIV patients on a 
yearly basis to take them on as patients. Specific guidelines should be developed by the 
team, stakeholders, and insurance companies to allow HIV patients to choose a 
specialized HIV clinician if the ones in their insurance network are not HIV specialized, 
and as such not equipped to treat them appropriately. Lastly, stakeholders and HIV 
programs should work with drug companies to offer periodic teachings on side effects 
and interactions of their approved HIV drugs not only to clinicians but also to insurance 
companies. The latter could be key in preventing the constant battle between insurers and 
patients attempting to avoid being forced to solely acquire a medication they know 
counteract severely with their current HIV regimen simply because it might be cheaper 





In regard to follow up appointments for their HIV care, the team should work 
with HIV programs to implement a reminder phone call or text message especially for 
this aging group. In fact, some participants did report noticing memory loss as they are 
progressively aging with the virus. Although they understand how crucial their HIV 
follow up appointments are and are strongly against missing them, one cannot control the 
forgetful mind. For instance, P1 stated, “I mean occasionally because of my memory loss 
I forget, I always ask them to give me a reminder call, but for the most part I am pretty on 
it.”  And P8 added, “I am having issues with memory and concentration. I just feel like 
I’m inappropriate to my age.” Memory loss is clearly becoming an issue for long-term 
survivors; as such, reminder calls or texts could be essential in ensuring they do not miss 
these crucial appointments. 
Overall and as stated above, these long-term survivors shared the impact of HIV 
on their daily lives, their feeling of being somewhat forgotten by this society, their need 
for activities that would create opportunities for them to socialize more, and their need 
for access to care to improve their physical appearance. Additionally, they shared their 
struggle to survive in this increasingly expensive society on low income, as P7 stated,  
Physically I can’t work more, and the other situation is that if I make one more 
dollar then I lose all my Medicare, I lose all my medication, and I can’t live like 
that. So, in that respect the biggest side effect is that we’re prisoners of our 





Finally, they shared their fear of tomorrow in this same society still lacking 
accommodations for those on the verge of losing their independence or those without 
enough savings to retire. For example, P6 stated,  
I suppose that the challenge that’s playing on my mind quite a bit right now 
would be the vision and the thought process of losing my driver’s license, and that 
will just be horrifying. Not to be too dramatic, but that loss of independence at 
this age – I’m only 63.  
And P8 stated,  
the impact of HIV and having been out of work for so long and been on disability 
and living barely above the poverty line is that at this point, while most of my 
friends have - own property and talk about retirement plans and 401Ks and things 
like that, I have no savings, no property, no retirement plan other than eventually I 
will go back on Social Security, either by disability or by actually retiring. But 
with no assets and no pension, no retirement savings, I’m hoping to be able to at 
least save something now that I am returning to work at 51. We’ll see how long I 
can continue working, but it’s a rather scary proposition.  
Specifically, if implemented, the recommendations of my study could directly 
impact long term HIV survivors struggling in a world where they have outlived most of 
their friends and are somewhat rejected by a community of their own. For instance, if 
proper access to care and procedures is made available to them, this could allow them to 





a better incentive to step out of their secluded shell with confidence. Additionally, if 
suggested programs are put in place, this could enable them to create new bonds, 
socialize more, and eventually embrace the outside world thus reducing any possibility of 
falling into depression. Also, with the majority of people “forced” into disability because 
of the effects of the virus, or for those still struggling to maintain employment and thus 
adequate housing, framing proper guidelines that would ensure they obtain some sort of 
housing and nutrition assistance, could positively impact their lives. In fact, as P8 stated 
“when you're not sure where you next meal is coming from, your doctor’s appointment 
two weeks from now might not be your first priority”.  
Finally, the study could also have a positive impact on the next generation of 
newly diagnosed individuals. P8 stated,  
With the younger newly diagnosed folks, 18 to 25 or even 18 to 30, they generally 
have no experience of having to take medication on a regular basis. No experience 
of having to engage in healthcare on a regular basis. Plus, they have no memory 
of how devastating HIV was. They never went to funerals two and three times a 
week the way that folks my age or just a little bit older than me did. They never 
watched friends die around them. So, getting them to understand the seriousness 
of the diagnosis and getting them to - having to grasp, mentally, at the age of 21 
that you’re gonna have to take medication for the whole rest of your life and you 
really can’t miss any dosages, is a pretty difficult thing to struggle with. And they 





their parent’s insurance whom they don’t want to be receiving statements or bills 
from the insurance company for HIV medication.  
Although this generation no longer has to face HIV as a death sentence, not only do they 
have to grasp the seriousness of their diagnosis, they are currently living in a society 
where there is of yet no available facilities to care for those aging with the virus and not 
enough specialized providers to address their HIV associated chronic conditions to cite a 
few. Despite the plethora of shared experiences from long-term survivors, as stakeholders 
work on better aging days for those living with the virus, this newer generation could 
benefit from mentorship from these long-term survivors, as well as guidance towards a 
brighter future. As P4 stated, “You go towards it. You embrace it. You deal with it. You 
don't walk away from it. You have to run towards it, and deal with it in a proactive way 
versus just sitting back.” Lastly, key information obtained through these long-term 
survivors could be used to shape guidelines that could improve the current and future 
lives of newly diagnosed patients. 
Conclusion 
This study was conducted to assess the living experiences of HIV-positive 
participants 50 years and older living and aging with the virus. To gather data, I 
conducted recorded telephones interviews with ten participants, which I later transcribed, 
prior to analyzing the data using Nvivo 11 software. The latter analysis led to three 
themes, which enabled me to grasp a more detailed understanding of the daily life 





participants described that upon freshly being diagnosed, they went from fear, to anger or 
denial, to a state of acceptance. Additionally, the majority described a series of challenges 
to constant survivorship as they continued on their journey. The latter journey has been 
met with daily struggles and unmet needs. In fact, most participants not only outlined 
their needs of today, more importantly they also shared their uncertainties of tomorrow. 
To that effect, some participants, in the wake of their body weakening overtime from the 
long-term effect of both the virus and ART, shared their fear of losing their independence 
before their time whether it be through disability as a direct result of HIV for instance or 
as P5 stated, through “aging and surviving with the virus in a society on low income.” On 
another note, some participants shared their fear of aging out with the virus in a society 
that does not yet have available assisted living facilities for their population group. For 
instance, P8 stated,  
looking forward I’m scared because you know I’m apprehensive about the 
availability of care, the availability of living arrangements and you know 
eventually, an assisted living facility or I suppose a nursing home. There are as 
yet no accommodations, there’s nothing that has been yet developed to address 
the needs of people living with HIV in those environments.  
It is imperative that additional research be conducted to ensure that this 
population does not age and face these challenges alone, as they felt when their journey 
began. On the contrary, the medical and scientific body in collaboration with stakeholders 





additional ones they might have, to ensure that the challenges they once faced when HIV 
was a death sentence do not resurface, and that they do not become prisoners of the now 
chronic disease. As much as they can advocate for themselves, we can also be their voice, 
we have to work together in ensuring their time spent on Earth is memorable and 
enjoyable in the outdoors rather than in solitude, behind closed doors, in fear of today and 
worry of tomorrow. As these survivors are fighting and holding out hope, we must 
continue to fight with them and for them, we must continue the quest for a cure. Because 
as P8 stated, “an HIV cure would be nice to improve my quality of life” and P2 added, “if 
somebody had a magic wand and could take HIV away from me, yeah, I mean that would 
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